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ABSTRACT 
NEZAHAT ÖZLEM ARAT: THE ROLE OF SHELTERIN COMPONENTS ON THE 
STRUCTURAL DYNAMICS OF TELOMERIC DNA  
(Under the direction of Jack D. Griffith) 
 
Telomeres are the nucleoprotein caps found at chromosome ends. They help to 
differentiate the chromosome ends from DNA double strand breaks and define the molecular 
clock of a cell. The molecular clock determines the number of times a cell can divide and 
when telomeres significantly shorten, cellular senescence or growth arrest occurs. Cancer 
cells reverse this process either by activating telomerase or by utilizing Alternative 
Lengthening of Telomeres (ALT). Suppression of ALT, regulation of telomerase, and end 
capping are all performed by the shelterin complex. The shelterin complex is composed of 
six proteins; TRF1, TRF2, Rap1, TIN2, TPP1 and Pot1. Rap1, TRF2 and Pot1 are important 
for the suppression of ALT and regulate the topology of the telomeric DNA. Telomeric DNA 
is composed of G-rich tandem repeats and this unique character facilitates the formation of 
higher order structures such as t-loops and G-quadruplexes. Eventhough both t-loops and G-
quadruplexes are important for end protection, they need to be resolved for 
replication/transcription complexes to progress. 
Presented here is an investigation into how Rap1, Pot1 and their associated complexes 
TRF2/Rap1 and Pot1/TPP1 mediate structural changes of telomeric DNA and whether t-
circles could act as a substrate for the telomere extension through ALT. We observed that 
hRap1 directly interacts with DNA and modulates the localization of TRF2 at telomeric ends 
 iv 
by increasing its affinity and specificity to telomeric sequences and telomeric junction sites. 
As a result, the TRF2/Rap1 complex can form more t-loops than TRF2 alone, presenting one 
possible mechanism of end protection and explanation of hRap1’s role. We also 
demonstrated that G-rich ss telomeric DNA exists as a beads-on-a-string conformation with 
each bead size ~500 nucleotides. Furthermore, we showed that Pot1 and the Pot1/TPP1 
complex can form filaments along G-rich ss telomeric DNA as they open up the G-
quadruplexes. These findings can explain how the telomeric DNA structure is modulated 
during replication. Additionally, we showed that only C-rich t-circles can act as a substrate 
for telomere extension by a rolling circle mechanism. These information all together 
demonstrate the importance of Rap1, TRF2 and Pot1 and can be used to explain how ALT 
initiates upon loss of the shelterin components. 
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CHAPTER 1: INTRODUCTION 
 
Human chromosomes end in 4-12 kb tandem repeat tracts of 5’-TTAGGG-3’ with a 3’ 
overhang (1). This repetitive DNA is bound by sequence-specific proteins called shelterins. 
Overall, this DNA-protein complex is called a telomere (2). Telomeres evolved to protect 
against two challenges that linear chromosome ends in eukaryotic organisms pose for cells. 
First, cells need to have some dispensible DNA at the ends of chromosomes to prevent the 
loss of genomic information, which would occur as a result of the end replication problem 
(2,3). During cell division, the lagging strand shortens with each cell division by the size of 
an Okazaki fragment (~150 nucleotides) (3). Not only do telomeres protect against the loss of 
genetic information but they also set a limit to the number of divisions a cell can undergo 
before telomeres shorten significantly and activate senescence (3,4). This is known as the 
Hayflick Limit.  
Second, linear chromosome ends need to be distinguished from double strand breaks to 
ensure chromosome stability. Telomeres hide the chromosome ends from DNA repair factors 
either by protein complexes present at chromosome ends or by forming higher order 
structures, such as telomere loops (t-loops). A t-loop forms by folding the single stranded 3’ 
overhang back and strand invades the upstream double strand telomeric DNA (5). In humans, 
shelterin is thought to cap chromosome ends and maintain telomere length by regulating 
telomerase activity. More specifically, the shelterin component TRF2 has been shown to 
facilitate and stabilize the t-loop structures in vitro (6). However, little is known about the 
regulation of t-loops and their formation by other telomere-associated factors.  
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Shelterin Complex Proteins  
 
Shelterin is composed of TRF1 and TRF2 (Telomeric Repeat binding Factor 1 and 2), 
Pot1 (Protection Of Telomeres 1), TIN2 (TRF2- and TRF1-Interacting Nuclear protein 2), 
Rap1 (the human ortholog of the yeast Repressor/Activator Protein 1) and TPP1 (also known 
as TINT1, PTOP, or PIP1) (7,8). These proteins are specific to and function at chromosome 
ends throughout the cell cycle (7). (Figure 1) 
 
TRF1 and TRF2: TRF1 was the first mammalian telomeric protein isolated due to its 
specificity for the mammalian duplex repeat tract (9-11). Shortly after, TRF2 was found by a 
homology search using TRF1 as a reference (12). Both TRF1 and TRF2 bind to DNA either 
as homodimers or oligomers, which increase their affinity for repetitive DNA, and thus 
explains their abundance at the telomere termini (13,14). Specificity for telomeric DNA is 
achieved by the C-terminal SANT/Myb-type DNA binding domains of TRF1 and TRF2, 
which recognize the 5’-YTAGGGTTR-3’ sequences in duplex telomeric DNA (13,15,16). 
TRF1 and TRF2 are highly homologous with the exception of their amino termini (14), in 
which TRF1’s N terminus is acidic while TRF2’s is basic (Gly/Arg-rich). This leads to 
different binding specificities. While TRF1 binds to and coats duplex repeats, binding of 
TRF2 is more structure specific and independent of the sequence (13,17,18). TRF2 prefers to 
bind to Holliday junctions, 3-way junctions and t-loops via its basic domain (16,17). 
Although both TRF1 and TRF2 have TRF homology domains (TRFH), which enables the 
oligomerization of TRFs, TRF1 and TRF2 do not interact directly (19).  
Human Rap1 (hRap1) is an ortholog of budding yeast Rap1(20). Budding yeast Rap1 binds 
to ds telomeric DNA directly and acts as a transcription factor (21-24). Human Rap1 has an 
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N-terminal BRCT domain (the C_terminal domain of a breast cancer susceptibility protein), 
a central myb and coil-coil domain followed by a C-terminal RCT domain (C-terminal Rap1-
specific protein-interaction domain) with Nuclear localization signal (NLS). hRap1 interacts 
with TRF2 through its RCT domain. This interaction is suggested to confer Rap1’s 
localization to telomeres because hRap1’s myb domain is neutral in charge (20). Recent 
studies demonstrated that hRap1 regulates transcription and prevents telomere fragility and 
recombination (25-27). How Rap1 exerts these functions remains to be solved.  
Pot1, the highly conserved shelterin component, was identified by its sequence homology to  
telomere end binding factors in Oxytricha nova (28). While humans have one Pot1 gene, 
mice have two Pot1 genes (Pot1a and Pot1b). Mammalian Pot1 has three OB 
(oligonucleotide/oligosaccharide binding) folds, which allow it to bind to single stranded 
DNA (29). However, OB folds are not enough for localization of Pot1 to telomeres in vivo 
because RPA competes for the same binding sites (30). Pot1’s interaction with TPP1 
outcompetes RPA and TPP1 targets Pot1 to telomeric DNA (31). 
TPP1 is the human homolog of the β subunit of protozoan telomere end binding complex 
(TEBPα-TEBPβ) suggesting that end capping by the Pot1-TPP1 complex is evolutionarily 
conserved (32). The Pot1-TPP1 complex regulates telomere length by acting as a 
processivity factor of telomerase (32). TPP1 forms the link between Pot1 and TIN2 through 
its central domain and C terminus (31,33) 
TIN2’s role at the telomeres is to essentially link the shelterin complex together. TIN2 can 
bind TRF1, TRF2, and TPP1, simultaneously and tether the double strand binding proteins to 
the ssDNA-binding protein POT1 (34). The interaction between TRF1 and TIN2 is through 
the TRFH domain of TRF1 and the FxLxP motif in the C terminus of TIN2 (35). TIN2 also 
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has two different sites in the N terminus that interact separately with the hinge domain of 
TRF2 and TPP1 (35,36). 
The name shelterin specifically refers to the six telomere proteins described above and 
the various subcomplexes that are formed. A TRF2/TIN2/TPP1 triple complex has been 
reported in addition to a TIN2/ TRF1/ TRF2/ TPP1 quaternary complex (36). Moreover, 
TRF2/Rap1 as well as Pot1/TPP1 double complexes are found in vivo (37). The biochemical 
properties of complexes can be different than the individual components. Therefore, the 
DNA binding properties of the subcomplexes and how they modulate the topology of the 
telomeric DNA needs to be elucidated.  
 
Figure 1: Shelterin complex components are shown with the domain and crystal structures. Domains with same 
colors are the ones for interaction among shelterin complex members. The lines denote the link between the 
interaction domains on different shelterin elements and the interactions of proteins with the telomeric DNA (7) 
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Shelterin and DNA Damage Response (DDR) 
 
Integrity, length and structure of telomeres are very important for their function. The 
shelterin complex and other telomere associated proteins cap the telomeric ends to prevent 
unnecessary DSB repair (38,39). Critically short or unprotected ends can trigger the DNA 
Damage Response (DDR) either through activation of Ataxia Telangiectasia Mutated (ATM) 
or Ataxia Telangiectasia and Rad3 related (ATR) proteins (40,41). Eventually telomeric ends 
become prone to end processing by Non-homologous End Joining (NHEJ) and Homology 
Directed Repair (HDR) (42,43). HDR at telomeres causes an unequal exchange of telomeric 
sequences between two sister chromatids or different chromosomes. This exchange would 
result in telomere length changes, terminal deletions and short telomeres in the daughter cell 
with deleterious effects. NHEJ at telomeres results in chromosome end-to-end fusions 
between sister chromatids (or dicentric chromosomes) that are prone to initiate breakage-
fusion-bridge (BFB) cycles in mitosis.  
Critically short or uncapped telomeres fuse and can initiate BFB cycles, which are 
deleterious for the cells. During anaphase of the cell cycle, the fused ends break by the force 
applied from the centromeres resulting in terminal deletions, amplifications and inversions of 
repeat sequences (44). These gross chromosomal rearrangements are common features of 
carcinogenesis and consistent with the changes in the expression levels of some telomere 
associated factors such as TRF2 (44-47). Loss of TRF2 leads to formation of telomere 
dysfunction induced foci (TIFs) and chromosome end to end fusions (48). This indicates that 
TRF2 is necessary for end protection. 
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NHEJ can be either canonical (c-NHEJ) or alternative (alt-NHEJ) and depending on 
which shelterin component is dysfuntional, either one is activated (48). While TRF2 deletion 
activates c-NHEJ, alt-NHEJ is activated by the deletion of Pot1-TPP1 complex (48). The 
reason for that difference can be the DDR pathway activated upon their loss because deletion 
of TRF2 and Pot1 result in activation of ATM and ATR pathways, respectively (49). In the 
Ku70/80-/- background, TRF2 and Pot1 a/b deletions results in a ~10% exchange of telomeric 
sequences between sister telomeres (T-SCEs) (50-52). T-SCEs indicate the presence of HDR 
at telomeres (53). Therefore, this data indicates that both proteins are important in 
suppressing HDR.  
So far, in vivo evidence revealing the function of hRap1 in suppression of unnecessary 
DNA repair at chromosome ends was impaired by the embryonic lethality of the Rap1 
knockout mouse. This problem was overcome by a conditional deletion of the Rap1 gene 
from Mouse embryonic fibroblasts (MEFs), complementation of conditional TRF2 knockout 
MEFs with a TRF2 mutant that cannot bind to Rap1 and mice without a functional Rap1 
gene (25,26,54). Unlike TRF2 and Pot1, deletion of Rap1 does not initiate DDR suggesting 
that Rap1 is dispensable for telomere capping (52). However, Rap1 deletions in Ku70/80 -/- 
results in higher number of T-SCEs (~10%) suggesting that mRap1 suppresses HDR (52). 
The exact mechanism of Rap1 mediated HDR suppression is unknown, yet there is evidence 
that Pot1 and Rap1 can cooperatively prevent initiation of HDR (55). Without Pot1a/b, Rap1 
cannot repress HDR, and in Rap1-/-/Ku-/- MEFs, Pot1 a/b alone cannot repress recombination 
(52,55). Similarly, TRF2 and Rap1 could work together to suppress recombination at 
telomeres because they exist as complex in vivo (20). In vitro evidence suggest that the 
TRF2/Rap1 complex is also important for the repression of NHEJ (27,56). This may involve 
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the recruitment and regulation of other protein(s). The TRF2/Rap1 complex is known to 
interact with DNA repair factors such as the MRN complex, Ku70/80 heterodimer and Slx4, 
which is a scaffold protein that binds to the HJ resolvase, nucleases and mismatch repair 
proteins (57-59). The exact mechanism of human Rap1 in DNA repair suppression at 
telomeres requires further study. 
 
Telomere length maintenance 
 
DNA polymerases can not fill in the last lagging strand gap, resulting in progressive 
shortening of chromosomes during cell division (60,61). In adults, somatic tissues have 
limited replicative capacity dependent on their telomere length (62). When cells reach their 
replicative capacity, they enter senescence and lose their ability to re-enter the active cell 
cycle (40,63,64). Lack of senescence and further cell divisions in the absence of functional 
tumor suppressors like p53 and retinoblastoma pushes the cells into a crisis phase (65). These 
cells have instability of karyotype, end-to-end fusions, visible genomic changes in the form 
of chromosome rearrangements, gain or loss of chromosome arms, deletions and 
amplifications due to the BFB cycles (44). To bypass crisis, cancer cells adopt two different 
mechanisms to increase telomere length: telomerase mediated telomere extension or 
alternative lengthening of telomeres by employing recombination. 
 
Telomerase 
 
Telomerase compensates for telomere attrition through de novo addition of TTAGGG 
repeats to the 3’ end of the DNA strand during replication (66,67). Telomerase is a reverse 
transcriptase consisting of two subunits and accessory proteins such as NHP2, NOP10, 
 8 
pontin-reptin, dyskerin and TCAB1 (68-71) . The catalytic subunit, TERT, adds the repeats 
onto the chromosome ends by using an associated RNA component as a template (TERC) 
while the accessory factors stabilize the TERC subunit and enable the assembly of the 
TERC-TERT complex (68,70,72). Telomerase activity is regulated by molecular chaperons 
like heat shock protein 90 (73) and some shelterin components (32). The activity and 
expression of telomerase is high in embryos and decreases as tissues differentiate, which 
correlates with the loss of proliferative potential (62,64). Adult tissues that have high levels 
of telomerase are dividing male germline cells, adult stem cells and activated immune cells 
(74,75). Also ~ 85% of cancer cells express telomerase at high levels to increase their 
replicative capacity (76). Therefore, it is important to understand how shelterin components 
regulate telomerase activity. 
 
Recombination mediated telomere lengthening 
 
Alternative lengthening of telomeres (ALT) was discovered in human cancer patients that 
are resistant to telomerase inhibitors, which constitutes ~ 10-15% of all cancers (76,77). ALT 
is observed in many cancer types but mainly in tumors of the mesenchymal origin such as 
glioblastoma multiforme, osteosarcoma and some soft tissue sarcomas as well as common 
cancers like breast carcinomas (78-84). There are no known therapeutic targets of ALT, 
therefore understanding its molecular mechanism is key for detection and treatment of 
cancers that extend their telomeres through ALT. 
Common characteristics of ALT cells that are not present in normal human cells are 
heterogenous (85) and rapidly changing telomere length (86,87), a high rate of recombination 
at the telomeres (88), extrachromosomal telomeric DNA (89,90) and ALT-asociated 
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promyelocytic leukemia nuclear bodies (ALT-PML or APBs) (91). APBs can contain 
telomeric chromatin and telomere associated proteins such as shelterin components and DNA 
repair, replication and recombination factors including RAD52, RAD51, MRN, WRN, BLM, 
TRF1, TRF2, RAD17, RAD9-RAD1-HUS1 (91-96). A cell line lacking telomerase without 
APBs managed to maintain its length suggesting that APBs aren’t required for ALT activity 
(97). 
 
Telomeric Circles 
 
Extrachromosomal telomeric DNA can be circular [double stranded (90,98) or partially 
single stranded (89,99)], linear (100,101) or the high molecular weight complex brached 
structure called a “t-complex”(89). T-circles were discovered in yeast in this laboratory by 
Lubomir Tomaska (102) and shown to be a hallmark of ALT by Anthony Cesare (90). The 
size of the double stranded circular DNA and t-circle, directly correlates with the size of the 
t-loops, thus t-circles are suggested to arise from the resolution of t-loops (98). Nbs1 and 
XRCC3 are required for the formation of t-circles in humans (103). Moreover, t-circle 
formation is elevated in cells that are lacking or are mutated in the TRF2 basic domain (98), 
Ku 86 (104), WRN helicase (98) or ORC2 (105). T-circles are also present in telomerase 
positive cells that have some telomerase components overexpressed (106). In that assay, 
telomere length reached a plateau after the cells were enriched in t-circles suggesting that t-
circle formation is a mechanism to prevent the overlengthening of telomeres (106). However, 
at early stages of development, X. laevis embryo contains significant amounts of t-circles, 
which reduces substantially in later stages (107). This suggests that t-circles are not only 
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important for telomere trimming and to keep telomere length at a steady state but also 
provides advantages during development. 
Single stranded C-rich circles (C-circles) are one marker of ALT cells and are formed of 
an intact C rich strand and a partial G rich strand (99). They are suggested to arise from 
nucleolytic degradation of t-circles but experimental evidence is lacking to prove this 
hypothesis. There are ~ 1000 C-circles per cell and these C-circles are 100 fold more 
abundant than G-circles (99). In contrast to t-circles there is a direct correlation between 
appearance of C-circles and onset of ALT activity (99). Furthermore, C-circles diminished 
when ALT was inhibited (99) suggesting that C-circles can be used in an assay for ALT 
prognosis but its exact role in telomere length maintenance by ALT needs further 
investigation.  
 
Models for Telomere Length Maintenance by ALT 
 
Unequal T-SCE model: Telomeric DNA contains nicks and gaps that would stall the 
replication forks (89) and may initiate recombinational repair. Therefore, telomeres may act 
as a substrate for T-SCEs (108). The frequency of telomere sister chromatid exchange events 
(T-SCEs) are higher in ALT cells than telomerase positive cells or somatic cells (88,109) 
providing evidence for this model. By this mechanism one daughter cell would have a longer 
telomere with a higher proliferative capacity while the other daughter cell would end up with 
a shorter telomere and lower proliferative capacity (110). However, this model accounts for 
prolonged proliferative capacity only if all the long telomeres are separated from all the short 
telomeres asymetrically, and that all the long telomeres are segregated into one daughter cell 
(111,112). Presence of such a telomere separation model has yet to be validated. 
 11 
 
Homologous recombination dependent DNA replication model: In this model, the new 
telomeric DNA is synthesized by using the adjacent telomeric DNA as a template (77,113). 
The templates can be a t-loop, a sister chromatid, an adjacent chromosome, a linear 
extrachromosomal telomeric DNA, t-circles or C-circles. Experimental evidence for the use 
of an adjacent chromosome as a template comes from a study where a DNA tag was placed 
into the telomeres of ALT cells. Tagged telomere numbers increased, suggesting that tag was 
copied from one telomere to another (113). In yeast, telomeric circles can be used as 
substrates for telomere extension through Rolling Circle Replication (RCR), and thus in 
humans t-circles or C-circles can be substrates for RCR as well (77,99,114). Circles can 
anneal to the 3’ G-rich overhang and get extended by RCR, which in turn can be a substrate 
for interchomosomal recombination. Moreover, this mechanism can explain the heterogenity 
and the rapid changes in ALT telomere length.  
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Figure 2: Mechanisms of telomere length regulation by ALT modified from (115). 
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Shelterin and telomere length regulation 
 
Inhibition of yRap1 function results in increased telomere length, while over-expression 
or increased localization of yRap1 to telomeres results in telomere shortening. Therefore the 
accepted model for telomere length regulation in yeast is a negative feedback loop (116-120). 
Mammalian Rap1 has different effects on telomere length, depending on the cell type. Upon 
deletion of Rap1 in MEFs, there is no significant effect on telomere length (121). However, a 
26% reduction in mean telomere length was observed in mouse epidermis lacking Rap1 
(121). Similarly, overexpression of hRap1 or its mutants (122,123) results in telomere 
lengthening, indicating that a potential role of mammalian Rap1 exists in telomerase 
regulation. 
Overexpression of TRF2 results in progressive shortening of telomeres, and this 
phenotype can be fully rescued by Xeroderma pigmentosum group F (XPF) deficiency (124). 
Moreover, TRF2 (ERCC1 and XPF1)(125) colocalize with factors in Nucleotide Excision 
Repair (NER) pathway indicating that TRF2 controls telomere length via recruitment of XPF 
to telomeric DNA. Moreover, TRF2 suppresses recombination at telomeres (126) and 
prevents enzymatic attack on four way junctions and t-loops (98). TRF2 also facilitates t-loop 
formation in vitro (127). Overexpression of a TRF2 mutant lacking the N terminal basic 
domain results in t-circle formation, which is a common feature of ALT cells (98). All 
together these data suggest that TRF2 can be a candidate protein in genesis of ALT by 
suppressing the resolution of telomeric recombination intermediates and by regulating 
telomeric recombination by t-loop formation.  
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While a double knockout of Pot1a/b in MEFs did not result in telomere length changes, 
(128), single knock out studies suggest that Pot1a deficient cells exhibit overall telomere 
lengthening  and 3’ overhang elongation (129). Moreover, overexpression of Pot1 mutant 
lacking the OB DNA binding domain in telomerase positive human cells resulted in telomere 
elongation when compared to wild type (130). The finding suggests that Pot1 inhibits 
telomerase action through its DNA binding ability. TPP1 is also a negative regulator of 
telomerase, potentially through its bridging funtion of Pot1 to TIN2 (131). Additionally, Pot1 
may have a role in telomere length regulation in ALT cells through its ability to regulate the 
replication of the G-rich strand, because inhibition of Pot1 results in an increase in the 
number of broken replication forks and telomeric replication events such as T-SCEs (132). It 
remains unknown how ALT is suppressed in normal cells, despite the presence of most of the 
molecules necessary for ALT. Therefore, understanding the role of the shelterin components 
in ALT is a key to understand the initiation of ALT.  
  
  
 15 
Table 1: Effect of shelterin components on telomere length regulation and the mutations 
applied. 
 Mutation Telomere Length Mechanism 
TRF2 Overexpression  Decrease XPF dependent 
 ΔB overexpression t-circles Increase ALT 
 Deletion in NEF No effect  
Rap1 Deletion in epidermis Decrease Telomerase 
 Overexpression Increase Telomerase 
Pot1a/b k/o in MEF No effect  
Pot1a Deletion Increase Telomerase 
Pot1 Mutated/OB overexpressed Increase Telomerase 
Pot1/TPP1 Overexpression Increased T-SCE ALT/Telomerase? 
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Scope of Dissertation 
 
Presented here is an investigation into the DNA binding properties of hRap1, hPot1 and 
their subcomplexes; TRF2/Rap1 and TPP1/Pot1 as well as an in vitro assay to test the role of 
C circles in ALT. The goal of the work presented here was to understand how shelterin 
components and subcomplexes modulate the higher order DNA structures formed at 
telomeres and how C-circles can mediate telomere extension. 
Chapter 2 describes the DNA binding characteristics of hRap1 determined using EM and 
quantitative gel electrophoresis techniques. The role of Rap1 in modulation of hTRF2’s DNA 
binding properties are also described. This discovery disproves the established knowledge 
about hRap1 that hRap1 cannot bind to DNA on its own. Moreover, the findings here provide 
a model for how hRap1 suppresses NHEJ and how the TRF2/Rap1 complex localizes to 
telomeres, regulates t-loop formation and suppresses NHEJ.  
Chapter 3 provides structural information about the G quadruplexes formed during 
telomere extension and how Pot1 and Pot1-TPP1 open up these motifs. EM, CD 
spectrophotometry and gel electrophoresis analysis showed that the G-quadruplex motifs can 
be very complex uniform structures which are composed of ~500 nts in hybrid form. The 
very big complex character of G-quadruplex motifs can explain how telomeric G-
quadruplexes can be a burden during DNA replication. We also showed that Pot1 and Pot1-
TPP1 forms filaments along G motifs to open up the quadruplexes. These results provides a 
model how hPot1 relieves replicative stress and how Pot1-TPP1 increase telomerase 
processivity. 
Chapter 4 describes development of a model replication system using nanocircles and 
model telomere DNA as a template. EM and gel electrophoresis showed that only C-rich 
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circles among extratelomeric DNA molecules can act as a template. This data is consistent 
with roll and spread mechanism of telomere extension and provides information about how 
C-circles are utilized in ALT cells for telomere maintenance. Moreover, the extension rate  
was ~ 130 bp/sec and the products ranged from 4 to 50 kb explaining why ALT cells have a 
big variation in their length and why telomere length in ALT cells change rapidly.  
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CHAPTER 2: HUMAN RAP1 INTERACTS DIRECTLY WITH TELOMERIC DNA 
AND REGULATES TRF2 LOCALIZATION AT THE TELOMERE 
 
 
SUMMARY  
The TRF2/Rap1 complex suppresses Non-homologous end joining and interacts with 
DNA-PKcs to prevent end joining. We previously demonstrated that hTRF2 is a double 
strand telomere binding protein that forms t-loops in vitro and recognizes 3- and 4- way 
junctions independent of DNA sequence. How the DNA binding characteristics of hTRF2 to 
DNA is altered in the presence of hRap1 however is not known. Here we utilized EM and 
quantitative gel retardation to characterize the DNA binding properties of hRap1 and the 
TRF2/Rap1 complex. Both gel filtration chromatography and mass analysis from 2D 
projections showed that the TRF2/Rap1 complex exists in solution and binds to DNA as a 
complex consisting of 4 monomer of each of hRap1 and hTRF2. EM revealed for the first 
time that hRap1 binds to DNA templates in the absence of hTRF2 with a preference for 
double strand-single strand junctions in a sequence independent manner. When hTRF2 and 
hRap1 are in a complex, its affinity for ds telomeric sequences is 2-fold higher than TRF2 
alone and more than 10-fold higher for telomeric 3’ ends. This suggests that as hTRF2 
recruits hRap1 to telomeric sequences, hRap1 alters the affinity of hTRF2 and its binding 
preference on telomeric DNA. Moreover, the TRF2/Rap1 complex has a higher ability to re-
model telomeric DNA than either component alone. This finding underlies the importance of 
complex formation between hRap1 and hTRF2 for telomere function and end protection. 
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INTRODUCTION 
 
Eukaryotic chromosomes ends are protected by a combination of looped or fold-back 
structures and proteins that generate protective telomere-specific complexes (1,2). In higher 
eukaryotes, a set of six telomere-specific proteins termed the shelterins has been identified 
which are central to telomere maintenance (3). In addition to the shelterins, the reverse 
transcriptase telomerase and many general DNA replication and repair factors complete the 
repertoire of proteins protecting telomere ends (4-6). TRF1 and TRF2 bind directly to duplex 
telomeric repeats through their myb domains, while the other shelterins are suggested to 
scaffold onto these two proteins (7,8). TRF2 appears to be most central to these events. In 
vitro TRF2 is able to generate t-loop structures in which the 3’ single strand (ss) overhang of 
the telomere invades the internal double strand (ds) telomere regions to generate a large 
duplex loop (1,9). Further, TRF2 is able to bind another shelterin factor, Rap1, as well as 
numerous DNA replication and repair factors including Ku 70, Apollo, MRN complex, 
WRN, Fen1, ORC1, PARP1 and PARP2 presumably to tether these factors near the 
chromosome end (10,11). The complex of TRF2 and Rap1 prevents NHEJ and works with 
DNA-PK to suppress joining of telomere ends and thus must be central to telomere 
maintenance and architecture (12,13).  
The importance of TRF2 has been documented by studies involving over-expression of 
dominant negative alleles and more recently inducible knockouts of TRF2 (14,15). These 
studies show that TRF2 suppresses NHEJ and prevents chromosome end-to-end fusions 
(14,15). Additionally, down regulation or loss of TRF2 activates the ATM kinase pathway, 
induces the formation of DNA damage induced foci, up-regulates p53 and arrests cells at the 
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G1/S checkpoint (16-18). The interaction of TRF2 with telomeric DNA has been examined 
in detail in vitro in this and other laboratories (9,19,20). The protein contains a single myb 
domain as well as a dimerization domain and a highly basic N terminus (7). Since two myb 
domains are needed for stable DNA binding, the homodimer of TRF2 represents the minimal 
oligomer required for stable binding to duplex telomeric DNA (21). TRF2 however is also 
able to bind to DNA in a non-sequence but structure-specific manner, mediated by the basic 
N terminus (19). These studies described first in this laboratory showed that telomeric DNA 
is highly prone to replication fork slippage and thus the binding of TRF2 to slipped structures 
may be key in stopping further fork slippage and preventing the generation of deleterious 
structures (19). Moreover, TRF2 prevents NHEJ at non-telomeric sites through its basic 
domain (22).   
hRap1 was first identified by yeast two hybrid analysis with hTRF2 as a bait (10).  hRap1 
binds directly to hTRF2 through its RCT domain and pull down experiments in human cell 
extracts have identified stable complexes of hTRF2 and hRap1 (2,10). hRap1 is more 
abundant in the cell than hTRF2 and immunodepletion of hRap1 results in a reduction of 
TRF2 levels (23). In contrast, lowering TRF2 with shRNA resulted in only a moderate 
change in the total Rap1 levels due to its overabundance (24). This may indicate that in 
contrast to mouse Rap1, hRap1 does not require hTRF2 for its stability in the cell. It was 
suggested that hRap1 does not bind DNA directly and is recruited to human telomeres by its 
binding partner hTRF2 (10). However, as observed by CHIP analysis, hTRF2 and hRap1 
have distinct and overlapping binding sites along the chromosome (25,26). Further, 
mammalian Rap1 is found at non-telomeric loci in addition to telomeres (25). Some of the 
non-telomeric sites have consensus (TTAGGG)2 motifs while others do not (25). The 
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localization of hRap1 to regions with TTAGGG sequences could be through its interaction 
with TRF2 but how it localizes to non-telomeric sites is not clear (26).  
Budding yeast Rap1 plays a role in transcription, telomere length regulation and end 
capping. Rap1 is the most conserved shelterin component among different species (27), and 
recently, hRap1 was shown to have similar functions to its yeast counterpart. hRap1 regulates 
the expression level of genes that are in close proximity to its binding sites and regulates 
telomere length through its BRCT domain (11,26). Moreover, Rap1 alone suppresses NHEJ 
in human extracts and HR in mouse cells (23,28). However significantly less is known about 
the function and role of Rap1 in human or mouse cells in the suppression of the DNA 
Damage Response. 
Our previous in vitro studies (9,19) of the interaction of TRF2 with telomeric DNA as 
well as Holiday junctions and replication forks have led to a better understanding of its role 
in telomere protection. To further understand the role of hRap1 alone or bound to hTRF2, it 
will be critical to determine how the binding of hRap1 to hTRF2 augments or modifies its 
binding to telomeric DNA and to unusual DNA structures. In this study we characterized the 
DNA binding ability of hRap1 to different model DNA templates in the absence of hTRF2 
and then tested how the binding preference and affinity is altered when hRap1 is in a 
complex with hTRF2. 
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EXPERIMENTAL PROCEDURES 
 
Preparation of DNA Molecules — A) Preparation of linear telomeric templates — The 
pRST5 plasmid contains ~575 bp of ds human telomeric DNA (9). A plasmid containing 
~1.1 kb telomeric repeats, pOST6, was prepared from pRST5 with expansive cloning as 
described in Stansel et al (9). The minichromosome template consists of two model telomeres 
joined at their non-telomeric ends so that ds telomeric DNA with 3’ ss overhangs are present 
at both ends. The minichromosome templates were prepared similarly to the model telomeres 
(9) by treating pRST5 with BsmBI and NotI followed by 3’ overhang ligation with a 1:10 
molar ratio of linear ds template to a 124 nt oligo consisting of 5’ TTAGGG 3’ repeats (IDT, 
Coralville, IA). The NotI digestion product has 5’ GGCC 3’ends that facilitate dimerization 
at the nontelomeric ends upon ligation. Blunt end DNA molecules were obtained by treating 
BsmBI digested pOST6 with S1 nuclease as described in the manufacturer’s protocol 
(Fermentas Inc., Glen Burnie, MD). To generate a template with a telomeric 5’ overhang, 
BsmBI digested pOST6 was treated with ExoIII on ice for 5 minutes as described in the 
manufacturer’s protocol (New England Biolabs, Ipswich, MA). A nontelomeric template 
with a 3’ overhang was generated by treating EcoRI digested pGLGAP, which does not 
contain telomeric repeats (29), with T7 exonuclease at room temperature for 40 seconds 
followed by incubation on ice for 5 minutes (New England Biolabs).   
 
B) Preparation of stalled replication forks and Holliday Junctions — To generate a circular 
ds DNA with a 400 nt single strand tail, pGLGAP plasmid was nicked using Nb.BbvCI (New 
England Biolabs) and the nicked strand was displaced by incubation with the Klenow 
fragment (exo–) of DNA polymerase I in the presence of dNTPs except for dCTP (29). To 
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make the tail ds with different gap sizes at the fork, primers were annealed to the ss tail and 
incubated with Klenow (exo-) polymerase in the absence of dGTP for 30 minutes at 37°C 
(30). Preparation of telomeric and nontelomeric Holliday Junctions were done as described 
(31).  
 
C) Preparation of DNA for EMSA — pRST1 plasmid, which contains a 154 bp ds telomeric 
insert, was digested with BsmBI and HindIII and the telomeric insert isolated by gel 
electrophoresis (QIAGEN, Germantown, MD). The purified insert was used as a ds telomeric 
template for EMSA after the 5’ ends were radiolabeled with [γ-32P]ATP in a standard T4 
Polynucleotide Kinase (PNK) reaction as described by the manufacturer (New England 
Biolabs). To generate a radiolabeled telomeric template with a 3’ overhang, the gel isolated 
duplex DNA was ligated to a G rich oligo with 8 telomeric repeats after the oligo was 
phosphorylated with [γ-32P]ATP from its 5’ end as described above. A nontelomeric template 
with a 3’ overhang was prepared from two oligos with sequences 
5’ATAGCTAGACATAGACCTAGGATTCCGTAGCTAGCACTGGCATACTGCTAGAT
CGCGATACTGGTCACTAGCTAGGCTACAGTCCTGACG 3’ and 5’ 
CGCGATCTAGCAGTATGCCAG 
TGCTAGCTACGGAATCCTAGGTCTATGTCTAGCTAT 3’ (MWG Operon, Huntsville, 
AL). Only oligo 1 was phosphorylated at its 5’ end with [γ-32P]ATP as described by the 
manufacturer with T4 PNK (New England Biolabs) and annealed to oligo # 2 with a gradual 
cool down from 90°C. 
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Purification of proteins — The full-length hRap1 and hTIN2 genes were purchased from 
Open Biosystems (Fisher Scientific, Pittsburg, PA) and the full-length hTRF2 gene was a gift 
of Dr. Christopher Counter. Each gene was cloned into the pFastBacHtA plasmid. The full 
length NH2-terminal His6-tagged hTRF2 was purified with a Talon™ metal affinity resin 
(Clontech, Palo Alto, CA) from Sf21 extracts as described (32) and stored in 20 mM Hepes 
(pH 7.5), 300 mM NaCl, 20% glycerol, 3 mM MgCl2, 1 mM DTT at -80°C. The full length 
NH2-terminal His6-tagged hRap1 was purified with Ni-NTA chromatography (QIAGEN, 
Germantown, MD) from Hi-5 cell extracts (10) and stored in 50 mM NaPO4 (pH 7.5), 300 
mM NaCl, 20% glycerol, 8 mM β-Mercaptoethanol (BME). Similarly, NH2-terminal His6-
tagged hTIN2 was purified with Ni-NTA chromatography (QIAGEN, Germantown, MD) 
from Sf21 extracts (33) and stored at -80°C in 50 mM NaPO4, 150 mM NaCl, 8 mM BME, 
20% glycerol. 
 
B) TRF2/Rap1 complex formation — TRF2/Rap1 complexes were formed by incubating 100 
µg of hTRF2 and 100 µg hRap1 on ice for 30 minutes in 10 mM Hepes (pH 7.5), 25 mM 
NaPO4, 300 mM NaCl, 4 mM BME, 1,5 mM MgCl2, 0.5 mM DTT and 20% glycerol, 
followed by size exclusion chromatography on Sepharose 6 (GE Healthcare, Piscataway, NJ) 
using an elution buffer of 20 mM Hepes (pH 7.5), 300 mM NaCl, 20% glycerol, 3 mM 
MgCl2 8 mM BME.  Fractions collected from the Sepharose 6 size exclusion column (GE 
Healthcare, Piscataway, NJ) were stored at -80°C. To determine the elution profile of the 
individual components, 100 µg of NH2-terminal His6-tagged hTRF2 or NH2-terminal His6-
tagged hRap1 proteins were passed through the Sepharose 6 size exclusion column (GE 
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Healthcare, Piscataway, NJ) in a buffer of 300 mM NaCl, 20 mM Hepes (pH 8.75) and 8 mM 
BME.  
 
EM analysis — A) Tungsten shadowcasting — DNA-protein complexes in the binding 
reaction mixture were cross-linked with 0.6% (w/v) gluteraldehyde for 5 minutes at room 
temperature and passed through 2-ml size exclusion columns with A5M beads (Agarose 
Bead Technologies, Spain) pre-equilibrated with 0.01 m Tris-HCl (pH 7.6), 0.1 mm EDTA. 
The cross-linked complexes were mixed with a buffer containing 2.5 mM spermidine, 
adsorbed to glow-charged carbon foil grids for 3 minutes and dehydrated with a series of 
water/ethanol washes, air-dried, and rotary shadowcast with tungsten at 1×10–6 torr as 
described (34). An FEI Tecnai 12 instrument (Hillsboro, OR) equipped with a Gatan Orius 
CCD camera (Gatan, Pleasanton, CA) at 40 kV was used to capture the images using Digital 
Micrograph software. Images for publication were arranged and contrast optimized using 
Adobe Photoshop CS5 (Adobe Systems, San Jose, CA). At least 100 molecules were scored 
in sequence as they were encountered at the EM and statistical analysis was done using 
Student’s t-test (Graphpad Software, Inc., La Jolla, CA) 
 
B) Negative staining and mass analysis — To generate the TRF2/Rap1 complex for negative 
staining, hTRF2 (200 ng) and hRap1 (200 ng) were incubated on ice for 30 minutes and then 
diluted to 20 ng/µl in 20 mM Hepes (pH 8.75) and 100 mM NaCl. To negative stain 
individual proteins, hRap1 or hTRF2 was diluted to 20 ng/µl as above and stained with 2% 
(w/v) uranyl acetate in water. Samples were examined in a Philips CM12 TEM at 80 kV and 
images captured on a Gatan First Light high sensitivity CCD camera (Gatan, Pleasanton, 
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CA). Negative stained images (1500-2000) for each protein were analyzed using ImageJ 
software (NIH, Bethesda, MD) for mass determination as described previously in numerous 
papers from this laboratory (31,35). Ferritin was used as a size standard for these 
experiments. 
 
C) Mass analysis of proteins bound to Holliday Junctions — DNA-protein complexes were 
tungsten shadowcast as described above and a size standard (ferritin) was prepared side-by-
side for each experiment (31). Images were captured as above (Tecnai 12, Hillsboro, OR). 
For each protein ~ 100 images were analyzed with ImageJ software to determine the area 
distribution (NIH, Bethesda, MD). 
 
Electrophoretic Mobility Shift Assays — DNA binding reactions were done at room 
temperature for 20 minutes in 20 mM Tris (pH 8.0) at different protein concentrations and 5 
nM DNA template. Reactions were quenched with 2.5 mM EDTA, 5% glycerol, 0.25 mg 
Bromophenol Blue and 0.25 mg Xylene Cyanol and loaded onto a 4% native polyacrylamide 
gel. The dried gel was analyzed by autoradiography and imaged with a Typhoon 9400 
phosphoimager (Amersham Biosciences, Piscataway, NJ). Graphpad prism software was 
used for the nonlinear regression analysis to determine Kd values (GraphPad Software, Inc., 
La Jolla, CA). To verify that binding is specific to hRap1, a His-tagged antibody was used in 
the binding reactions as described above and the antibody amount in the reaction was 
determined according to manufacturer’s protocol (ABGENT, San Diego, CA).  
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RESULTS 
 
hRap1 binds to minichromosomes, Holliday Junctions and Replication forks 
The DNA binding ability of hRap1 has been previously examined using gel shift assays 
employing short (72 bp) ds human telomeric DNA or ss and ds yeast telomeric DNA (10). 
By this approach, hRap1 did not show significant binding to telomeric DNA. However, short 
DNAs do not recapitulate the full telomere architecture, and thus we used EM to examine the 
DNA binding ability of hRap1 using DNA templates in the range of 0.7 to 7 kb including the 
minichromosomes, Holliday Junctions and replication forks illustrated in Figure 2.1A-C. 
The minichromosome template mimics a human chromosome with a 6 kb segment of 
plasmid DNA flanked by ~ 575 bp of repeating 5’ TTAGGG 3’ duplex repeats at both ends 
terminating in 120 nt, 3’ TTAGGG overhangs (Figure 2.1A). We also used a Holliday 
junction (HJ) with 175 bp intersecting arms, and a similar size telomeric HJ with 2 TTAGGG 
repeats at the intersection site (Figure 2.1B) (36). Finally, a replication fork was created 
from a 3.4 kb duplex circle that contains a ~ 400-bp displaced arm with different gap sizes at 
the fork (30), which enables us to test the ability of proteins to bind to junction sites through 
structure recognition as these replication forks do not contain telomere repeats (Figure 
2.1C).  
Human Rap1 was purified from insect cells. To examine the binding preference of each 
protein on the different DNA templates, sub-saturating ratios of protein:DNA were used to 
gain evenly sized particles on the DNA and to avoid a significant number of aggregates 
consisting of multiple DNAs bound together by protein. To do this, different protein:DNA 
ratios were tested and the ones which yielded roughly one-half of the DNA bound by protein 
while less than 10% was in aggregates were selected. The optimal binding for each protein 
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was observed at 14:1 and 26:1 protein tetramers:DNA molar ratios for hTRF2 and hRap1 
respectively. hTIN2 interacts with hTRF2 (37) but has not been shown to interact with 
telomeric DNA directly while hTRF2’s behavior with similar templates has been studied 
previously (19,37).  Thus hTIN2 and hTRF2 were used as controls in these assays. 
Supplementary figure 1 shows the binding of hTRF2 to the minichromosomes 
(Supplementary 2.1A), a replication fork with a 25 nt gap (Gap25) (Supplementary 2.1B), 
and telomeric HJs (Supplementary 2.1C). In each case, hTRF2 bound to the 3- and 4- way 
junctions confirming previous findings (19). Under the same binding conditions even with as 
many as 568 hTIN2 protein monomers to DNA, TIN2 did not bind to the minichromosome 
(data not shown). hRap1 localized to the telomeric ends of the minichromosomes (Figure 
2.1D), to the crossover of the telomeric HJ (Figure 2.1E), and to the fork junction of Gap25 
DNA (Figure 2.1F). In each case, the protein-bound DNA species showed a uniformly sized 
and shaped protein particle bound. hRap1 has an N terminal histidine tag and to confirm that 
the binding activity was specific to hRap1, we did an EMSA with an anti-His tag antibody. 
DNA template used was 57 nt long with 33 nt 3’ overhang and did not contain any telomeric 
sequences (Experimental Procedures). The lack of a shift with antibody alone but the 
presence of a supershift with the antibody and hRap1 confirmed the binding activity to be 
specific to hRap1 (Figure 2.1G). These data suggest that hRap1 has the ability to directly 
interact with DNA.  
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Figure 2.1: hRap1 binds to model DNA templates. Schematic representations of the 
minichromosome (A), replication fork with 25 nt gap (B) and Holliday Junction templates (C).  Black 
regions correspond to the telomeric DNA. Tungsten shadowcast images of hRap1 illustrate protein 
bound to the minichromosome (D), replication fork (E) and telomeric Holliday junction template (F). 
Shown in reverse contrast. Size bar in (D) and (F) are 100 nm and is 50 nm in (E). EMSA with 4% 
PAGE demonstrates hRap1 bound to the nontelomeric template with a 3’ overhang in the presence 
and absence of anti 6X his antibody (G). 
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Supplementary Figure 2.1: hTRF2 localizes to the ds-ss junctions on different DNA templates. 
Tungsten shadowcast images of hTRF2 bound to the minichromosome (A), replication fork with a 25 
nt gap (B), and the telomeric HJ template (C) shown in reverse contrast. Bars correspond to 100 nm 
in A and B and 50 nm in C. 
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hRap1 binds to ds-ss junctions independent of sequence but prefers 3’ overhang structures 
over 5’ overhangs 
We previously showed that hTRF2 binds to replication forks, HJs, and ds-ss overhangs 
independent of sequence (19). Because hRap1 bound to the same DNA templates, we wished 
to quantify binding of hRap1 with different DNA templates. On replication forks and 
Holliday junctions, the majority of hRap1 localized to the junction site (Figure 2.2A) at 
comparable levels to hTRF2 confirming that hRap1 recognizes 3- and 4- way junctions. 
Scoring the distribution of hRap1 molecules along the minichromosomes, we found that 
hRap1 localizes to the termini of the minichromosomes containing the 3’ ds-ss junction site 
with a ~ 13 fold greater preference over the ds telomeric DNA (Figure 2.2B). When the 3’ ss 
overhang was removed, the total hRap1-binding dropped to background levels, confirming 
that hRap1 specifically recognizes the ds-ss junctions of minichromosomes (Figure 2.2C). 
We wanted to determine if localization of hRap1 to minichromosomes is sequence or 
structure dependent. Human telomeres engaged in Homologous recombination (HR) 
dependent telomere maintenance have 5’ C rich overhangs (38). To further probe the 
structure specificity of hRap1 binding, we used a linear template containing a 1.1 kb 
telomeric tract at one end and then digested it with a 3’ to 5’ exonuclease to generate 5’ tails 
up to 340 nt in length (as seen by EM). hRap1 was found to preferentially bind to DNA with 
3’ overhangs over 5’ ends as does hTRF2 (Figure 2.2D). To examine the sequence 
specificity of hRap1 binding at junction sites, a linear 3.5 kb nontelomeric plasmid DNA was 
digested with a 5’ to 3’ exonuclease to generate 3’ overhangs of average ~ 560 nts. hRap1 
localized to the 3’ ends of the telomeric and nontelomeric linear templates equally with no 
statistical difference, while hTRF2 showed a preference for telomeric DNA with 3’ 
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overhangs (Figure 2.2E). There was no significant effect of the presence of telomeric 
sequences at HJs on hRap1 binding (Supplementary Figure 2.2). These findings suggest 
that hRap1 has a strong preference for 3’ ends on linear templates and has the ability to 
interact with the ds-ss junction sites independent of their sequence, in contrast to hTRF2. The 
3’ G rich overhang at telomeric ends is a requirement for the formation of a t-loop (1,9) and 
thus we addressed the t-loop forming ability of hRap1. Despite binding to junction sites, 
hRap1 formed t-loops 5-fold less well when compared to hTRF2 suggesting that this is not a 
strong activity for hRap1 alone (Figure 2.2F). 
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Figure 2.2: hRap1 recognizes the 3’ ds-ss junction structures independent of sequence. (A) illustrates 
that both hRap1 and TRF2 have a strong and similar preference for  binding to the ss-ds junction at 
replication fork with a 25 nt gap and the crossover at the HJ.  (B) illustrates the strong preference for 
hRap1 binding to the end of the minichromosome containing a 3’ ss extension as contrasted to 
binding internally along the ds telomeric segment. (C) showed the strong preference for hRAP1 
binding  to the minichromosome containing a 3’ ss extension as contrasted to the same but blunt 
ended DNA. (D) shows that both hRap1 and TRF2 prefer to bind at the ss-ds junction of DNAs with a 
3’ overhang as contrasted to a 5’ overhang. (E) compares the binding to DNAs containing 3’ 
overhangs joined to either telomeric ds segments or non-telomeric.  (F) compares the t-loop formation 
percentages of hRap1 and hTRF2 on the minichromosome. Each binding experiment was done in 
triplicate and at least 100 molecules were counted. * is p<0.05, ** is p<0.01 and p<0.001 is 
represented by ***. 
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Supplementary Figure 2.2: Junction preference of hRap1 binding to telomeric and nontelomeric 
Holliday junctions. hRap1 binds telomeric and nontelomeric HJ’s primarily at the junction site 
without a sequence preference. Binding experiments in quadruplicate with 100 molecules counted for 
each. 
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The hTRF2/Rap1 complex is formed from 4 molecules of hRap1 and 4 molecules of hTRF2 
The oligomeric states of proteins can influence their binding characteristics. hTRF2 and 
hRap1 exist in a complex at human telomeres (2,39) and while it has been demonstrated that 
they exist in a 1:1 ratio (39), their oligomeric state is unknown. Therefore, we analyzed the 
mass of hRap1, hTRF2 and the TRF2/Rap1 complexes in the absence of DNA by EM. The 
TRF2/Rap1 complex was formed from the purified proteins (Experimental Procedures). In 
negative stained fields of hTRF2 (Figure 2.3A), Rap1 (Figure 2.3B), and the TRF2/Rap1 
complex (Figure 2.3C) a variety of particle sizes and shapes were observed for all three, but 
in each case there was a predominant particle and there was a clear size difference between 
hTRF2, hRap1 and the TRF2/Rap1 complex. 
To obtain estimates for the mass of the predominant species in each preparation, we 
compared their projected areas in the negative stained images to that of ferritin as carried out 
in previous studies (31). The projected area distributions of the TRF2/Rap1 complex showed 
a wider range than that of hTRF2 or hRap1 (Figure 2.3D) and presents a good example of a 
positively skewed Gaussian distribution (Supplementary Figure 2.3D) which could result, 
for example, from a cylindrical shape for the TRF2/Rap1 complex rather than spherical shape 
as observed in hTRF2 and hRap1 where the size distribution would be much more narrow. 
Analysis of 715-2135 particles (Experimental Procedures) yielded an estimated mass of 136 
± 0.4 kDa for hTRF2, 221 ± 0.3 kDa for hRap1 and 496  ± 1.0 kDa for the TRF2/Rap1 
complex (Table 2.1).  
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Figure 2.3: Mass and oligomeric state analysis of hRap1, hTRF2 and the hRap1/TRF2 complex. 
Representative negative stained images of hTRF2 (A), hRap1 (B) and the TRF2/Rap1 complex (C) are 
shown as fields and an array of selected single particles at higher magnification.  Bars are equivalent to 
200 nm. Area distributions of single protein particles and Ferritin as a size standard were calculated 
from 2D projections of the EM images (D). The TRF2/Rap1 complex was separated using 10% SDS-
PAGE and stained with Coomassie Orange to determine the ratio of hRap1 to hTRF2 (E). 
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Supplementary Figure 2.3: Area distributions of hTRF2, hRap1 and the TRF2/Rap1 complex from 
2D projections of negative stained EM images. The mean and standard error values derived from the 
frequency distributions of the areas with Gaussian fits of Ferritin (A), hTRF2 (B), hRap1 (C) and the 
TRF2/Rap1 complex (D) are summarized in table (E). 
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Size exclusion chromatography was used to confirm the EM results. The TRF2/Rap1 
complex (Experimental Procedures), hRap1, and hTRF2 were passed through a Sepharose S6 
matrix and each fraction analyzed by SDS-PAGE followed by Coomassie Blue or Coomassie 
Orange staining (Supplementary Figure 2.4A and B). Based on parallel filtration of mass 
standards using the same column, hTRF2 eluted in a single peak equivalent to a mass of 121 
kDa, and hRap1 eluted in a wider peak with a mass of 285 kDa. When hTRF2 was in a 
complex with hRap1 there was a significant shift of the peak in the elution profiles. The co-
complex was found to elute as a wide peak with a mass of ~ 496-514 kDa likely due to the 
high glycerol concentration of the column buffer (Supplementary Figure 2.4C). To 
determine the TRF2 to Rap1 ratio in the complex, SDS gel electrophoresis of the TRF2/Rap1 
complex was carried out and the gel stained with a quantitative dye, Coomassie Orange.  
Analysis using Image J software (NIH) revealed that hTRF2 and hRap1 are in 1:1.17 ratio 
(Figure 2.3E) confirming previous findings (39). In summary, similar masses were obtained 
from the EM and gel filtration: 121 to 136 kDa for hTRF2, 221 to 285 kDa for hRap1, and 
496 to 514 kDa for the TRF2/Rap1 complex. The mass estimates derived by EM and gel 
filtration are in good agreement, but in the future, other methods may be applied to further 
confirm these findings. 
To deduce the oligomeric state corresponding to these masses, we used published protein 
values, determined by SDS-PAGE, as a reference (hTRF2 ~ 70 kDa, hRap1 ~ 60 kDa) (39). 
The calculated masses based on the DNA sequence do not take into account post-
translational modifications and these can change the mass and shape of the protein and thus 
their mobility on size exclusion chromatography. Indeed, hTRF2 is known to migrate at a 
much higher apparent mass in gel filtration than its calculated mass and one explanation 
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offered is its flexible structure due to the presence of the long unstructured linker domain 
(21). The values equate to a dimer for TRF2, and a tetramer for hRap1. Even though various 
combinations are possible because hRap1 exists as a tetramer and hTRF2 is stable as a dimer 
in solution and they exist in 1:1 ratio, we conclude that the TRF2/Rap1 complex consists of a 
4:4 complex consisting of one tetramer of hRap1 and either two dimers of hTRF2 or a 
tetramer of both proteins (Table 2.1). 
 
  Calculated Mass (kDa) 
Expected Mass 
(kDa) 
Oligomeric 
State 
  Size Exclusion 
Chromatography hTRF2 121 140 Dimer 
 hRap1 285 240 Tetramer 
 TRF2/Rap1 514 520 
Tetramer each 
of TRF2 and 
Rap1 
 hTRF2 136 140 Dimer 
Negative 
Staining hRap1 221 240 Tetramer 
 TRF2/Rap1 496 520 
Tetramer each 
of TRF2 and 
Rap1 
 
Table 2.1: Size analysis of hRap1, hTRF2 and the TRF2/Rap1 complex in solution. The estimated 
mass values obtained from the statistical analysis of the area distributions derived from negative 
staining as in Figure 3 and the size exclusion chromatography (supplementary figure 4) are shown 
with the corresponding oligomeric states. 
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Supplementary Figure 2.4: Analysis of mass and oligomeric state of hTRF2, hRap1 and the 
TRF2/Rap1 complex by size exclusion chromatography. Elution profiles of each protein obtained 
from Superose 6 column are shown in (A) with the peak values pointed with arrows. Fractions 
corresponding to every 0.9 ml were loaded on to a 10% SDSPAGE and stained with either Coomassie 
Orange (hTRF2 and hRap1) or Coomassie Blue stain (the TRF2/Rap1 complex) (B). The oligomeric 
state, estimated mass of the each protein with the corresponding elution volumes and the expected 
size of each protein (C). 
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The TRF2/Rap1 complex recognizes 3- and 4- way junctions and binds to DNA in as a 4:4 
complex 
hRap1 and hTRF2 are present at human telomeres and have been identified in cell 
extracts in complex with each other. However, little is known about the binding preference of 
this complex on different templates or whether the affinity of the complex is different from 
its components. To examine the binding preference of the TRF2/Rap1 complex we used the 
same model junction templates described above and found that a molar ratio of 7:1 
TRF2/Rap1 complex to DNA provided optimal binding for EM studies (Figure 2.4 and 
Figure 2.5). The TRF2/Rap1 complex bound to the Gap25 and telomeric HJ DNAs in a 
manner similar to hRap1 and hTRF2 alone (Figure 2.4A and B), and localized specifically 
to the junction of gap25 and telomeric HJ DNAs (Figure 2.4C). No significant difference in 
binding or preference was observed on the telomeric HJ versus nontelomeric HJs (Figure 
2.4D). These results suggest that the 4:4 complex of TRF2/Rap1 can also recognize 3- and 4- 
way junctions independent of sequences. 
When mass analysis was carried out on tungsten shadow cast proteins bound to telomeric 
HJ DNA (Table 2.2) (Corresponding Gaussian distributions are in Supplementary Figure 
2.5), as described above, the masses obtained were 276 kDa for hRap1 and 476 kDa for the 
TRF2/Rap1 complex, which were consistent with the negative staining and gel filtration 
values. The only exception was that the estimated mass for hTRF2 was 315 kDa arguing that 
it is a tetramer when it is bound to DNA, consistent with the observation of Fouche et al (19). 
Therefore, hTRF2 and hRap1 bind to telomeric HJ as tetramers while the TRF2/Rap1 
complex binds to telomeric HJs as a 4:4 complex of each protein. 
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Figure 2.4: The hTRF2/Rap1 complex recognizes replication forks and Holliday junctions. The 
TRF2/Rap1 complex localizes to the junction site of the replication fork (A) and the telomeric HJ 
DNA (B). Junction preference of the protein bound molecules on the DNA templates is in (C), while 
(D) represents the sequence preference of the hTRF2/Rap1 complex on the HJ DNAs. Each EM 
binding reaction was done in triplicate and 100 molecules each were counted. * is p<0.05, ** is 
p<0.01 and p<0.001 is represented by ***. 
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Supplementary Figure 2.5: The area distributions of hTRF2, hRap1 and the TRF2/Rap1 complex on 
telomeric Holliday Junction DNA. Gaussian fits on the 2D area projections, and the frequency 
distributions of each protein are shown in (A-E). Ferritin in (A) is the size standard for the hTRF2 
mass analysis while Ferritin in (C) is the size standard for the mass analysis of hRap1 (D) and the 
TRF2/Rap1 complex (E). Table (F) summarizes the mean area, standard error and the 95% 
confidence interval for each protein. 
 
 Sample 
Number of 
molecules 
counted 
Mean Area 
(pixel) 
Calculated 
Mass 
(kDa) 
95% 
Confidence 
Interval +/- 
(kDa) 
Number of 
oligomers 
Bound to 
Telomeric 
Holliday 
Junction 
TRF2 168 13771 315 1.6 Tetramer 
Rap1 87 10472 256 2.1 Tetramer 
TRF2/Rap1 
Complex 119 15823 475 3.3 
Tetramer 
of TRF2 
and Rap1 
 
Table 2.2: Mass and oligomeric state of hRap1, hTRF2 and the TRF2/Rap1 complex on telomeric 
Holliday junctions. Mass, mean area and the oligomeric state of each protein were obtained from the 
2D projection analysis of the tungsten shadowcast images as in Figures 2.1 and 2.4).  Masses were 
calculated based on using ferritin as a size standard. Area distributions with Gaussian fits are shown 
in Supplementary Figure 2.5. 
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The TRF2/Rap1 complex has higher specificity for telomeric DNA and junction structures 
than hTRF2 or hRap1 alone 
Incubation of the TRF2/Rap1 complex with the minichromosome template revealed 
binding along the internal duplex telomeric region (Figure 2.5A), at the ends with the ds-ss 
junction (Figure 2.5B), or both (Figure 2.5C). Since the duplex telomeric DNA constitutes 
1/12 of the total DNA length from each end of the minichromosome molecule, we were able 
to verify binding at the ds telomeric regions by measuring the length of the DNA from its end 
to the protein-binding site. When protein molecules were examined in detail, from 60 
examples, it appeared that the ds DNA passed through the TRF2/Rap1 complex as contrasted 
to binding on one side (Figure 2.5E). On the minichromosomes, the major preference for 
binding was to the ds-ss junction site (Figure 2.5F). However, ~ 1/3 of the bound complexes 
were localized to the internal duplex telomeric DNA, which is a significantly higher value 
than the percentage of hRap1 or hTRF2 molecules alone bound to the ds telomeric DNA on 
the minichromosome where the binding was at background levels for both proteins (Figure 
2.5G). These data suggest that in addition to binding to the DNA junction, the TRF2/Rap1 
complex has a second binding site available to it on the duplex telomeric DNA; the complex 
binds more readily to this region than hTRF2 and hRap1 alone.  
To examine the influence of sequence on TRF2/Rap1 complex binding we used the linear 
nontelomeric template with a 3’ overhang used for hRap1 binding reactions (described 
above). Under the same reaction conditions, the amount of the TRF2/Rap1 complex bound to 
the nontelomeric template was 2.5-fold less than to the minichromosomes (Figure 2.5H). On 
the minichromosome, the majority of the TRF2/Rap1 complexes were observed at the ds-ss 
junction site while on the nontelomeric linear template, no preferential binding was observed 
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(data not shown). These observations reveal that the TRF2/Rap1 complex has high 
specificity for telomeric sequences with a major preference being the ds-ss junction site at the 
end of the telomere. 
The TRF2/Rap1 complex formed a new structure with the minichromosome template in 
which both ends of the DNA were joined by the protein complex into a circle: 9% of the 
DNA was observed in this form (Figure 2.5D). Neither hRap1 nor hTRF2 alone exhibited 
this property (data not shown). Intermolecular bridges between two or more DNA molecules 
were present but at very low levels, likely reflecting the low DNA concentration used in the 
binding reaction. As the TRF2/Rap1 complex concentration was increased, the amount of 
circles, which might be a different form of t-loops, increased. When the TRF2/Rap1 complex 
concentration was titrated down to a lower level where hTRF2 no longer makes t-loops, the 
percentage of DNAs arranged into t-loops by the TRF2/Rap1 complex was 9% (Figure 2.5I). 
This finding suggests that the TRF2/Rap1 complex has higher capacity to re-model telomeric 
DNA than TRF2 or Rap1 alone. 
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Figure 2.5: The binding properties of the TRF2/Rap1 complex along the minichromosome. Tungsten 
shadowcast images of the TRF2/Rap1 complex on the minichromosome illustrate the protein bound 
to the ds-ss junction and/or to the ds telomeric DNA (A-C).  An example of the TRF2/Rap1 complex 
bringing the ends of the minichromosome together to form a circle is depicted in (D).  Bars in (A-D) 
are equivalent to 100 nm. In high magnification images, the ds telomeric DNA appears to pass 
through the TRF2/Rap1 complex (E).  Analysis of the binding preference of the TRF2/Rap1 complex 
along the minichromosome DNA is in (F), showing significant binding to the internal duplex 
telomeric sequences.  (G) further compares the binding percentages of hRap1, hTRF2 and the 
complex to the ds telomeric DNA segments of the minichromosomes. The effect of DNA sequence 
on the binding of the TRF2/Rap1 is shown in (H). (I) demonstrates the comparison of the t-loops 
formed by the TRF2/Rap1 complex and hTRF2 at 10 nM protein concentration. Corresponding p 
values are shown by the different number of stars on each graph as in Figure 2. 
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Kd values for DNA binding confirm the EM observations 
The higher specificity of the TRF2/Rap1 complex binding to telomeric sequences, 
observed by EM, could be due to a change in the substrate affinity when TRF2 and Rap1 
form the 4:4 complex. To further explore this, we determined the Kd values of the two 
individual proteins and the complex on telomeric and nontelomeric DNA templates. A 
telomeric duplex DNA template of 154 bp with or without a 3’ 54 mer G rich overhang and a 
nontelomeric template with a 57 bp ds region that has a 33 nt 3’ overhang were prepared, 
incubated with TRF2, Rap1 or the TRF2/Rap1 complex in similar binding conditions to the 
EM assays and quantified as described in Experimental Procedures. Table 2.3 summarizes 
the Kd values obtained for each template and protein, and the Hill coefficients determined for 
the telomeric 3’ overhang DNA. Typical EMSA gels are shown in Supplementary Figure 
2.6 and graphs are shown in Supplementary Figure 2.7. Hill coefficients on the model 
telomere template are 2.4 ± 0.4 for hRap1, 5.3 ± 1.3 for hTRF2, and 3.3 ± 0.6 for the 
complex. All values are above 1.5 showing that each protein has positive cooperativity of 
binding.  hRap1 has the lowest affinity for ds telomeric DNA (Kd of 265 ± 57 nM), and has 
very similar affinity for telomeric and nontelomeric 3’ overhang structures (119 ± 12 nM and 
161 ± 25.3 nM). This data is consistent with the EM observations and confirms that hRap1 
prefers ds-ss junction sites irrespective of sequence. hTRF2 binds 3 times tighter to ds 
telomeric regions than hRap1 and both hRap1 and hTRF2 have similar affinities for 
nontelomeric junctions (161 ± 25.3 and 133 ±16.36 nM). The Kd of hTRF2 on ds telomeric 
DNA is lower than the previously published value of 180 nM (40). The major reason for the 
tighter binding we observed could be the higher pH of the binding buffer, which inhibited 
TRF2 aggregation in solution. When telomeric sequences are present, the affinity of hTRF2 
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for junction sites is nearly 2 times that of hRap1. Consistent with EM, hTRF2 prefers 
telomeric junction sites over nontelomeric while hRap1 has a slight preference for telomeric 
junction sites.  
When both proteins were present in a 4:4 complex, we observed a great increase in the 
affinity for telomeric DNA. The binding affinity increased a minimum of 2-fold on ds 
telomeric DNA and ~10 fold on the model telomere structure containing a 3’ overhang. The 
TRF2/Rap1 complex has a 5 fold higher affinity for 3’ ds-ss junctions than ds telomeric 
regions. The TRF2/Rap1 complex cannot bind to the nontelomeric 3’ overhang structures 
even if the molarity of protein used in the reaction was up to 3 times the molarity in other 
binding reactions. The significant increase in affinity of the TRF2/Rap1 complex for internal 
duplex telomeric regions and for telomere 3’ overhang structures explains the dual binding of 
the TRF2/Rap1 complex along the minichromosome.  
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 Hill coefficient 
 
KD (nM) 
 
 
 
Telomeric 3’ 
overhang 
 
 
Duplex 
Telomere 
Template 
 
 
Nontelomeric 3’ 
overhang 
 
hRap1 
 
2.4 ± 0.4 118.9 ± 12.1 265.0 ± 57.2 161.3 ± 25.3 
 
hTRF2 
 
5.3 ± 1.3 64.7 ± 3.4 85.5 ± 11.6 133.0 ± 16.4 
 
hTRF2/hRap1 
 
3.3 ± 0.6 5.8 ± 0.3 37.0 ± 9.1 No Binding 
 
 
Table 2.3: Affinity of hRap1, hTRF2 and the TRF2/Rap1 complex on telomeric and nontelomeric 
DNA templates. The dissociation constants of hRap1, hTRF2 and the TRF2/Rap1 complex on the 
telomeric and nontelomeric DNA templates with a 3’ overhang or on the duplex telomere DNA are 
presented derived from electrophoretic experiments shown in the supplementary figures 6 and 7.  The 
Hill coefficient values of each protein on the model telomeric DNA is shown with the error values. 
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Supplementary Figure 2.6: EMSA analysis of hTRF2, hRap1 and the TRF2/Rap1 complex on 
radiolabeled templates. Linear duplex telomeric DNA and the nontelomeric 3’ overhang template 
were labeled from their 5’ ends with 32P while the model telomeric DNA with a 3’ overhang was 
labeled from its 3’overhang (Experimental Procedures). The binding mixtures were performed in 
parallel and electrophoresed on 4% native polyacrylamide gels. The results are shown over different 
ranges of protein concentration due to large differences in the binding affinity. The concentrations of 
hRap1 in the DNA binding reactions were up to 458 nM (model telomere DNA), 3.2 µM 
(nontelomeric 3’ overhang DNA), and 3.7 µM (linear duplex telomere DNA) while the concentrations 
of hTRF2 in the reactions were up to 1.5 µM for all DNA templates and the concentrations of the 
TRF2/Rap1 complex were up to 15 nM (model telomere DNA) and 62 nM (nontelomeric 3’ overhang 
DNA and linear duplex telomere DNA). 
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Supplementary Figure 2.7: Binding affinity of hRap1, hTRF2 and the complex on different DNA 
templates. Curves shown were obtained by fitting data points obtained from EMSAs with one site 
specific Hill plot (Graphpad prism software) except that the TRF2/Rap1 complex on duplex telomere 
DNA data points were fit with one site specific binding without Hill plot. Concentrations are shown 
in nM. 
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DISCUSSION 
 
To understand the role of hRap1 at telomeres, we studied the DNA binding 
characteristics of hRap1 and the TRF2/Rap1 complex on different DNA templates that mimic 
telomeric structures. In this study, we demonstrated that hRap1 directly interacts with ds-ss 
DNA junctions in the absence of hTRF2. The specificity of hRap1 for junction sites is 
structure specific rather than sequence specific. The dissociation rates of hRap1 and hTRF2 
at nontelomeric 3’ ds-ss junction sites are similar in value but in the presence of adjoining 
duplex telomeric DNA, hTRF2 shows tighter binding. Each protein binds to DNA as a 
tetramer and with positive cooperativity. The TRF2/Rap1 complex is ~ 500 kDa and consists 
of 4 molecules each of TRF2 and Rap1. When hRap1 and hTRF2 form a complex, the 
binding specificity for telomeric DNA increases significantly. As the affinity for ds telomeric 
DNA increases by more than 2-fold, the affinity for the 3’ telomeric ds-ss junction sites 
increases by more than 10-fold. Interestingly, the affinity of the TRF2/Rap1 complex for 
linear nontelomeric DNA with a 3’ overhang is lost, indicating that upon complex formation, 
there is a significant change in substrate specificity. 
In this work we found that hRap1 directly binds to DNA and has a preference for ds-ss 
junction sites. However, it was previously reported that hRap1 does not bind to DNA on its 
own but rather needs hTRF2 for binding (10). The reason for this contradiction is most likely 
the different sets of DNA templates employed. Li et al tested the DNA binding ability of 
hRap1 using a 72 bp DNA template with ds human telomeric repeats or ds and ss yeast 
telomeric DNA templates and did not observe binding upon addition of hRap1. They 
suggested that the lack of binding was due to the neutral character of the myb domain. We 
used much longer DNA templates and ones with ds-ss junction structures or with 3- and 4- 
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way junctions. We observed that hRap1 does not bind ds telomeric DNA but has high 
preference for ds-ss junctions. Moreover, hRap1 has similar Kd values for telomeric and 
nontelomeric ds-ss junctions demonstrating that its myb domain does not directly bind to 
telomeric duplex DNA, and NMR studies revealed that the myb domain does not contain 
charged residues on the surface (41) in contrast to the myb domain of hTRF2, which is 
positively charged (40). On the other hand, the affinity of hTRF2 for ds-ss ends increases in 
the presence of telomeric sequences, which could reflect the presence of its positively 
charged myb domain. Thus, hRap1 appears to recognize ds-ss junction structures in the 
absence of hTRF2 and without a sequence preference. 
Previously, Li et al failed to detect a change in the dissociation rate of hTRF2 when 
TRF2 is in complex with hRap1. With a similar template we observed a 2-fold increase in 
binding affinity for ds telomeric DNA and 10-fold increase in binding affinity for 3’ 
telomeric ds-ss ends. The reason of the difference may lie in the assay conditions. In their 
assay, hTRF2 and hRap1 were added to the ds telomeric DNA sequentially and DNA was 
already bound by hTRF2 when hRap1 was added. However, in our assays, the TRF2/Rap1 
complex was formed first. Consistent with their finding (10), we did not observe any positive 
cooperativity of binding on a duplex telomere template. In contrast, the TRF2/Rap1 complex 
shows positive cooperativity of binding in the presence of a 3’ overhang structure and the 
affinity of binding increases by 10-fold compared to TRF2 alone. 
We observed that both hRap1 and hTRF2 have the ability to bind to nontelomeric 
junction sites with similar affinities, raising the question what domain is responsible for the 
DNA binding ability of hRap1. We previously showed that the N terminal basic domain 
facilitates the binding of hTRF2 to junction structures independent of sequence through a 16 
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amino acid stretch with 8 positive charges (19). Similarly, an 18 amino acid stretch with 5 
positive charges is present at the N terminal BRCT domain of hRap1 (10). This is consistent 
with the finding of a single BRCT domain involved in the DNA binding of TopBP1 (42), 
XRCC1 (43) and Replication factor C (44) to ds-ss junctions. Thus, the BRCT domain of 
hRap1 may account for its binding to these ds-ss junctions. Alteration of telomere length 
upon deletion of the BRCT domain in Rap1 underlines the importance of this domain for its 
function (11,45). In the future, further analysis with deletion mutants should help elucidate 
the role of the BRCT domain of hRap1, including how the binding of hRap1 to DNA is 
affected by its interaction with hTRF2, and how the binding properties of hTRF2 to DNA are 
affected when it is complexed with hRap1. It is always possible that the effect of hRap1 on 
hTRF2 is dependent on its DNA binding activity and that the increase in its affinity for 
telomeric DNA may be due to allosteric interaction between hRap1 and hTRF2. Moreover, 
the DNA binding activity of hRap1 may be important for non-telomeric functions at internal 
sites on the chromosomes, but at the telomere, requires hTRF2 as a partner.  
hRap1 binds to junction sites and also modulates the binding of hTRF2 along linear 
telomeric DNA by facilitating a positive cooperativity of binding and by increasing its 
affinity for telomeric sequences. Moreover, we found that the duplex telomeric region is 
required for binding of the complex since even if the 3’ overhang structure was present, the 
TRF2/Rap1 complex could not bind when duplex telomeric sequences were absent. Indeed 
the TRF2/Rap1 complex bound to the ds telomeric DNA in the absence of a 3’ ds-ss junction 
with a ~ 2 fold higher affinity than the individual components. The observation that one 
fourths of the TRF2/Rap1 complexes localized within the ds telomeric region and three 
fourth of the TRF2/Rap1 complexes were at the ds-ss junction site (or both at the junction 
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site and the ds telomeric DNA) indicate that once the 3’ overhang is available, the 
TRF2/Rap1 complexes can slide and until it reaches the ds-ss junction where it binds tighter. 
These observations together lead to the following model. 
During telomere extension, the newly synthesized DNA will be exposed and needs to be 
coated with histones and/or shelterin components that bind to the ds telomeric DNA. The 3’ 
overhang is generated by the end processing machinery later in S-phase, and thus should not 
be available as a binding site (46). We propose that (Figure 2.6) TRF2 and Rap1 bind to the 
ds telomeric DNA as a complex due to the higher affinity of the complex for ds telomeric 
DNA than either individual component. Once the 3’ overhang is formed the TRF2/Rap1 
complex slides to the junction site and it remain due to its ~ 6-fold lower Kd value for the 
junction over duplex telomeric DNA, and thus covers the open telomere end. On long 
telomeres the TRF2/Rap1 complex could initiate t-loop formation and prevent DDR or as the 
telomere length becomes shorter (to a level where the t-loops cannot be formed) then with its 
very high affinity for the 3’ ds-ss telomeric end, the TRF2/Rap1 complex could suppress the 
unnecessary DDR by blocking the end and making it less accessible to DNA repair proteins. 
Indeed, the finding that very short telomeres without t-loops exist stably in vivo (47), that the 
TRF2/Rap1 complex can prevent NHEJ of telomeres with less than 10 repeats and in the 
absence of Rap1, can only be compensated by significantly high amounts of hTRF2 to 
facilitate end protection (12,48) provide support to this model. Depending on what parameter 
one measures, the loss of Rap1 in cells may be considered to be important for end protection 
or not (12,28). This illustrates importance of further work that will better link end protection 
in vivo with the physical complexes and structures formed at telomere by the shelterin. 
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Figure 2.6: Model for the TRF2/Rap1 complex loading onto and protecting the telomere. (1) The 
nontelomeric and the telomeric DNA are presented in full lines and in dashed lines, respectively. (2) 
The new telomeric DNA is synthesized in S-phase. (3) hTRF2 and hRap1 bind to the newly 
synthesized ds telomeric DNA as a complex and then end resection occurs forming the 3’ overhang.  
(4) The TRF2/Rap1 complexes slide along the ds telomeric DNA towards the newly formed 3’ 
overhang. (5) End protection by the TRF2/Rap1 complex occurs through t-loop formation or simply 
by blocking the exposed end. (6) In the absence of hTRF2, hRap1 binds to the junction site to prevent 
NHEJ (or HDR in mice) and in the absence of hRap1, hTRF2 prevents DDR by forming t-loops. 
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“This research was originally published in Journal of Biological Chemistry. Nezahat Ozlem 
Arat, Jack D. Griffith. Human Rap1 interacts directly with telomeric DNA and regulates 
TRF2 localization at the telomere. Journal of Biological Chemistry. 2012; 287(50):41583-94. 
© the American Society for Biochemistry and Molecular Biology.” 
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CHAPTER 3: STRUCTURAL CHARACTERIZATION OF LONG G-RICH 
TELOMERIC SINGLE STRANDED DNA AND FILAMENTS FORMED BY 
HUMAN POT1 AND THE HUMAN POT1-TPP1 COMPLEX 
 
SUMMARY 
G-quadruplexes have various functions in the cells, ranging from regulation of telomerase 
to controlling expression of onco-genes such as c-Myc, c-Kit, KRAS, pRb and Bcl-2. 
Understanding the structure of the G-quadruplexes is key to understanding their function. 
Short oligonucleotides are of limited use in modeling the G-quadruplexes formed during 
human telomere extension or telomeric transcription, which are of much greater size. 
Therefore we have utilized an in vitro telomere extension system to generate high molecular 
weight ssDNA capable of forming G-quadruplexes. Electron Microscopy was used to 
determine the structure of this long human G-rich DNA and its interaction with hPot1 and the 
Pot1/TPP1 complex. Here we provide the first evidence of G-quadruplex motifs as uniform 
beads, and with each bead being composed of ~487 nucleotides. These are the longest 
quadruplex structures yet identified. Moreover, we show that hPot1 forms filaments along the 
single stranded DNA as it opens up the G-quadruplexes. Similarly, the hPot1/TPP1 complex 
also form filaments and these filaments are more rigid than hPot1 filaments indicating that 
the DNA binding properties of hPot1 are changed upon complex formation with hTPP1. At 
the 3’ telomeric overhang hPot1 wraps the G-rich DNA around itself. These findings together 
can explain how hPot1 relieves replicative stress of C-strand replication and how the Pot1-
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TPP1 complex can act as telomerase processivity factor while hPot1 can protect telomeric 
end from exonuclease action.  
 
INTRODUCTION 
 
Runs of Guanines in DNA and RNA molecules tend to form higher order structures, 
called G-quadruplexes (1). G-quadruplexes arise from G-tetrads (G4) which are four 
guanines assembled by Hoogsteen base pairing (2). Computational analysis revealed that 
there are >375,000 G-quadruplex motifs in the human genome and these motifs cluster in 
specific regions frequently at oncogene promoters, 5’ untranslated regions (UTRs), 
mitotic/meiotic DSB sites, ribosomal DNA, minisatellites and immunoglobulin heavy chain 
switch region and telomeres (3-5). The presence of G-quadruplexes at distinct sites suggests 
that G-quadruplexes may be important regulators of biological functions including gene 
expression, recombination and telomere extension. Therefore, these higher order structures 
are a significant target for drug design. 
Human telomeres end with a G-rich single stranded 3’ overhang of 100-200nt in length 
(6). Oligonucleotides with telomeric sequences show banding patterns in non-denaturing 
polyacrylamide gels suggesting that telomeric overhangs can form G4 in vitro (7). 
Quadruplexes formed within the telomeric overhang inhibit the activity of telomerase, which 
is overexpressed in ~85% of cancers (8). The telomere binding protein Pot1 binds to the 
telomeric overhang (9), prevents unnecessary activation of ATR dependent double strand 
break repair (DSBR) at chromosome ends (10) and regulates G-quadruplex formation at the 
telomeric ends (11). Telomere uncapping and telomere length phenotypes that arise in the 
absence of hPot1 reveal the importance of hPot1 in telomere end protection (12,13). Despite 
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hPot1 having two oligonucleotide/oligosaccharide (OB) folds, TPP1 is required for the 
correct localization of hPot1 to telomeres (14) increasing its affinity for telomeric DNA by 
10-fold in vitro (15,16). Moreover, TPP1 recruits telomerase in vivo (16) while the hPot1-
TPP1 complex increases telomerase processivity in vitro (15) suggesting an important role of 
the hPot1-TPP1 complex during telomere length maintenance. 
The opportunity for Hoogsten base-pairing frequency increases during DNA replication, 
transcription and recombination (17) as duplex DNA is melted and the simple strands are 
exposed. This may be particularly the case during DNA replication where gaps transiently 
occur on the lagging strand that would increase the chance of G4 formation. G4 DNA cannot 
act as a template for the replication machinery and this may cause replication fork stalling, 
which in turn results in replicative stress (18). Telomeric DNA has an especially high risk of 
G4 formation during telomere replication because of its G-rich repetitive nature and 
propensity of the fork to slip backwards (19). Therefore, mammalian telomeres resemble 
fragile sites and additional factors like TRF1 (20) and/or RecQ helicases are required for 
their efficient replication (21,22). In WRN (a RecQ helicase) deficient cells, hPot1 is 
required for efficient telomere C-rich strand replication (23). However, the exact mechanism 
how hPot1 compensates for WRN loss remains unknown. To understand the structure of G 
quadruplexes formed at telomeres during replication and telomeric transcription, we analyzed 
the structure of long single stranded human telomeric DNA and asked how hPot1 and hPot1-
TPP1 complexes regulate these higher ordered structures. 
 
 
 
 77 
EXPERIMENTAL PROCEDURES 
 
DNA Templates- The model telomere template was synthesized as previously described (24). 
Briefly, a plasmid (pOST6) was linearized with BsmBI and NotI restriction enzymes (New 
England Biolabs Inc., Ipswich, MA) and different sized oligonucleotides (see below) were 
ligated to one end to generate a duplex DNA with either a 54, 90 or 120 nt 3' terminated 
single stranded tail (IDT, Coralville, IA) (24).  
To create the 5'-Flap DNA substrate the plasmid pRST5Nick (19) containing a C-less 
cassette was nicked using Nb.BbvCI (New England Biolabs Inc.). A 575 nt ssDNA 5’ Flap 
was displaced using Klenow fragment (exo-) (New England Biolabs Inc.) in a strand 
displacement reaction in the presence of 0.5 mM of dTTP, dATP and dGTP (19). The 
template was cleaned using Zymo clean and concentrator spin columns (Zymo Research, 
Irvine, CA). 
Telomeric ssDNA circles were synthesized using oligonucleotides with either G-rich or 
C-rich sequences (see below) containing 20 telomeric repeats (IDT, Coralville, IA). Oligos of 
124 or 120 nt were ligated using CircLigaseTM and the remnant linear oligos were digested 
with ExoI and Exo III (New England Biolabs Inc.) according to the manufacturers 
instructions (Epicentre Biotechnologies, Madison, WI). Circular products were confirmed by 
visualization on a 7% denaturing PAGE.  
To synthesize the long single stranded G-rich DNA template, a model telomere template 
with a 3’ G-rich overhang was annealed to 120mer C-rich circles in 1:10 molar excess and 
extended by Φ29 polymerase for 16 hours as described by the manufacturer (New England 
Biolabs Inc.). For EM analysis, the newly synthesized DNA was deproteinized with 20 µg 
proteinase K (Roche, Indianapolis, Indiana), 0.02M EDTA and 0.4% SDS in a 50 µl volume 
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and passed over a 2ml column of 2% agarose beads (Agarose Bead Technologies, Spain). 
Long C-rich DNA was synthesized using 124mer G-rich circles and 120mer C-rich 
complementary oligonucleotide similar to as described above. 
 
Oligonucleotide sequences-  
58mer: 5’-phosAGGG(TTAGGG)9-3’,  
94 mer: 5’-phosAGGG(TTAGGG)15-3’,  
124mer: 5’-phosAGGG(TTAGGG)20-3’,  
120mer: 5’-phos(AATCCC)20-3’ 
 
Purification of human Pot1- Baculovirus for GST-hPot1v1 was kindly provided by Ming Lei 
(25). For protein expression, 500ml of SF9 insect cells in Sf-900 II SFM media (Invitrogen 
GIBCO, Grand Island, NY). 1x106 cells per ml were infected with a multiplicity of infection 
(MOI) of 1. After 48hrs cells were pelleted and stored at -80°C. Cells were lysed in 50ml of 
Buffer A (50mM Tris 7.6, 400mM NaCl, 0.1% NP40 and 10% glycerol) for 30 minutes on 
ice and the lysate was sonicated and cleared at 15000 rpm for 1 hour. The cleared lysate was 
incubated with 2ml of glutathione beads (Clontech Laboratories Inc., Mountain View, CA) 
pre-equilibrated with buffer A for 1 hour at 4°C followed by extensive washing with Buffer 
B (50mM Tris pH7.6, 150mM NaCl, 10% glycerol). Untagged hPot1 was cleaved from the 
glutathione beads by adding protease 3°C (10 units) to the wash buffer and incubated 
overnight at 4°C with rotation. To remove the protease from hPot1, the sample was 
subsequently incubated with Talon™ metal affinity resin (Clontech, Palo Alto, CA) to 
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capture the histidine-tagged protease 3°C. Human Pot1 was stored in 50mM Tris pH7.6, 
150mM NaCl, 5mM DTT, 20% glycerol and stored at -80°C. 
 
Purification of TPP1- the His-Sumo-TPP1(87-545) construct was a gift of Dr. Ming Lei. His-
Sumo-TPP1 was expressed in Escherichia coli BL21 DE3 cells with 1 mM 1-thio-β-D-
galactopyranoside (IPTG) (Roche, Indianapolis, Indiana) for 4 hours at 37°C, purified as 
described in Sowd et al (26) and stored in 50 mM Tris pH 8.0, 150 mM NaCl, 20% glycerol, 
250 mM Imidazole.  
The hTPP1-Pot1 complex was formed by incubating equal masses of hPot1 and hTPP1 
proteins on ice for 45 min. The complex was used for the DNA binding reactions. 
 
Circular dichroism Spectral Analysis- For CD spectral analysis, synthesized DNA molecules 
were extracted in phenol/chloroform followed by one chloroform/Isoamyl alcohol wash and 
ethanol precipitation. G-rich ss DNA was dissolved in double distilled water and diluted to 
416 ng/µl in the presence of either 150 mM KCl with 5 mM KPO4, 150 mM NaCl with 
NaPO4 or no salt. Similarly, C-rich DNA was diluted to 165 ng/µl in the presence or absence 
of 150 mM KCl and 5 mM KPO4. DNA samples containing salt were melted at 95°C for 5 
minutes and gradually cooled down to 4°C with 1°C decrease per minute. CD analysis of G-
rich and C-rich ss telomeric DNA was performed at the Macromolecular Interactions Facility 
(University of North Carolina at Chapel Hill, NC) using Chirascan Plus fitted with a Peltier 
temperature control unit (Applied Photophysics Ltd, Leatherhead, UK). CD values were 
recorded at 25°C from 220 nm to 320 nm with 0.5 nm step sizes in a cuvette with a 1 mm 
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path length. Baselines of buffers were subtracted from the CD of DNA molecules and 
smoothed with Chirascan Prodata software. 
 
DNA-protein binding reactions- To determine the mass of protein that is bound to the model 
telomere overhang (50 or 90 nucleotides), 234 nM Pot1 or 76 nM Pot1-TPP1 complex was 
incubated with 2.9 nM DNA template for 15 minutes at 37°C. To form filaments on long ss 
telomeric DNA, 140 nM of hPot1 or hPot1-TPP1 complex was incubated with 1500 ng DNA 
in 50 µl of 10 mM Tris-HCl (pH 7.5) and 0.1 mM EDTA. DNA-protein complexes were 
diluted to 150 µl without gluteraldehyde fixation and 20 µl of each sample were prepared for 
EM as described below.  
Electron Microscopy- DNA and DNA-protein complexes were adsorbed onto copper EM 
supports covered with thin carbon foils for 3 minutes in the presence of a buffer containing 
2.5 nM or 0.3 nM spermidine. Samples were washed in water followed by a series of ethanol 
dehydration steps, air-dried, and rotary shadowcast with tungsten at 1x106 torr (27).Samples 
were visualized using a Tecnai 12 TEM (FEI Inc., Hillsboro, OR) at 40kV and images were 
collected on a Gatan Orius CCD camera (Gatan, Pleasanton, CA) with supporting software 
(Gatan).  
 
Image Analysis- The lengths and widths of hPot1, hPot1/TPP1 filaments were measured from 
digital micrographs using an Orius CCD camera with supporting software (Gatan). Image J 
software (NIH, Bethesda, MD) was used to analyze the 2D projections of the G-beads and 
the proteins bound at the telomeric overhangs. The 2D projections of the proteins were 
analyzed by ImageJ (NIH) software and converted to mass in kDa as described earlier (28) 
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using ferritin and streptavidin as standards. The kink angles and the length of DNA-protein 
filaments were also analyzed with ImageJ (NIH). For the statistical analysis Graphpad Prism 
5 Student’s t-test was used (Graphpad Software, Inc., La Jolla, CA).  Images for publication 
were arranged and contrast optimized using Adobe Photoshop CS5 (Adobe Systems, San 
Jose, CA). 
RESULTS 
 
G-rich telomeric DNA exists as a “beads on a string” conformation 
Analyzing the structure of G quadruplexes formed at telomeres is important for 
understanding the mechanism of telomere replication/transcription and how telomerase is 
inhibited by the quadruplexes. It is not clear yet if long telomeric DNA has distinct structural 
features or shares similar characteristics with shorter oligonucleotides. To mimic the 
structure of quadruplexes formed during replication/transcription at telomeres, single 
stranded telomeric DNAs up to 16 kbs long were synthesized using a model telomeric DNA 
and G- or C-rich nanocircles as a template for extension by Phi29 polymerase. The length 
was hard to measure because we do not know how either the C-rich or G-rich DNA is 
compacted. If it has the same extension as ds DNA, then the molecules would range from 
465 to 16000 nucleotides and the mean length would be ~3500 nts (Supplementary Figure 
3.1A). However, it is likely that the G-rich ss DNA is more compact, making them even 
longer. Double stranded DNA after tungsten coating is ~30 Å wide (Data not shown). 
However, the G-rich ss DNA appear much thicker and beaded (Figure 3.1C). Its width 
varies from 83 Å to 117 Å, with the diameter of the beads being 67 to 95 Å. In contrast to G-
rich ss DNA (Figure 3.1B), C-rich ss DNA does not form defined structures and its width is 
18 ± 6 Å (Figure 3.1A). Higher magnification images show that ss G-rich DNA is composed 
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of bead units attached by thin ss linker DNA (Figure 3.1C). This data suggests that G-rich 
DNA exists in a beads on a string like structure even in the absence of monovalent ions. 
 
 
 
 
Supplementary Figure 3.1: Frequency distribution of G rich ss DNA length (nm) determined by 
Gatan software. 
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Figure 3.1: G-rich and C-rich telomeric DNA present distinct structures by EM. Tungsten 
shadowcast images of long C-rich telomeric DNA does not show a defined structure (A) while G-rich 
ss telomeric DNA shows uniform units (B). Higher magnification images of G-rich ss DNA show 
bead motifs and arrows point the linker DNA between each bead motif (C). Images are shown in 
reverse contrast and each size bar is 50 nm. The 2D area projections of G-beads show a narrow 
distribution with a mean of 6278 Å2 (D) while the mean of TERRA’s area distribution is 7092 Å2 (E). 
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Each G quadruplex bead motif (G-bead) is composed of ~490 nts 
To determine the mass of each bead unit, the 2D area projections of G-beads were 
determined. The 2D area projection analysis of the bead units presents a narrow Gaussian 
distribution indicating that G-beads are uniformly sized structures with a mean of 6278 ± 67 
Å2 (Figure 3.1D). A G-rich RNA (TERRA) of ~575 nts was prepared as in Randall et al 
(29). When prepared for EM, TERRA looks like small single beads. (Supplementary Figure 
3.2). Comparison of the 2D projections provides a rough estimate for G-beads (Figure 3.1E) 
(28). Conversion of 2D area projections to mass illustrated that the size of G-beads is ~160 
kDa (Table 3.1). Regarding that 1 kb of ss DNA is 330 kDa, each bead could be composed 
of ~490 nts (Table 3.1). This data suggests that G-rich telomeric DNA is composed of 
uniform ~490 nts long bead motifs. 
 
Supplementary Figure 3.2: TERRA forms compact structures. Tungsten shadowcasted images of 
TERRA present higher order structure formation. Image is in reverse contrast and size bar equals to 
50 nm. 
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 # Particles Analyzed 
Mean Area 
(Å2) 
Standard 
Error (Å2) Mass (kDa) Length (nts) 
G-Beads 484 6278 67 161 ± 0.2 487 ± 5 
TERRA 212 7092 127 194 ± 0.2 575 
 
Table 3.1: Size analysis of G-beads. The estimated mass values obtained from the statistical analysis 
of the area distributions derived from tungsten shadowcast images as in Figure 1 and the 
corresponding ss DNA length. Area distributions with Gaussian fits are shown in Supplementary 
Figure 2. 
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Long telomeric G-rich DNA contain both parallel and antiparallel G quadruplexes 
G quadruplexes can exist in 3 different forms: parallel, antiparallel or hybrid structures. 
To gain structural information about the type of the G-quadruplexes formed along the long 
stretches of G-rich telomeric DNA, CD spectrophotometry was utilized in the presence or 
absence of monovalent ions. Introduction of Na+ favors antiparallel G quadruplexes as K+ 
favors both parallel and hybrid type G quadruplexes. In the absence of Na+ or K+, C-rich ss 
DNA has a single peak at 276 nm indicating no secondary structure formation while G-rich 
ss DNA presents a minimum at 247 nm and a maximum at 287 nm, which is a common 
feature of hybrid type G quadruplexes (Figure 3.2A). This data demonstrates that G-
quadruplexes can form during telomere extension and are stable structures even in the 
absence of monovalent ions. To mimic physiological conditions, 150 mM KCl was added to 
the ss G- or C-rich DNA and gradually cooled down. In the presence of KCl, C-rich ss DNA 
did not show a change in structure (Figure 3.2B). Surprisingly, the peak values of G-rich ss 
DNA remained the same upon addition of K+ or Na+ions (Figure 3.2C). G-quadruplexes 
formed by long DNA molecules are the highly stabile and the structure does not change with 
physiological levels of Na+ or K+.  
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Figure 3.2: G-rich ss telomeric DNA is composed of hybrid type G-quadruplexes. CD spectral 
analysis of C-rich and G-rich ss telomeric DNA in the absence of salt ions is shown in (A). (B) shows 
the CD spectra of C-rich ss DNA in the presence of 150 mM Na+ or no salt while (C) shows the CD 
spectra of G-rich ss telomeric DNA in the presence of 150 mM Na+ and K+ ions or no salt. 
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hPot1 and hPot1-TPP1 complex form filaments along G-rich DNA and open up the G-beads 
G quadruplexes should be unfolded in vivo so that the transcription or replication 
complexes can progress. It was previously demonstrated that hPot1 and the hPot1-TPP1 
complex could unfold G quadruplexes when its composed of four telomeric repeats. 
However, four repeats do not represent the actual telomere structure and the DNA binding 
properties of hPot1 and the hPot1-TPP1 complex on very long DNA templates has not been 
analyzed before. Moreover, we demonstrated that G quadruplexes are much bigger structures 
and each G-bead can be composed of ~ 490 nucleotides. Even though hPot1 and the 
hPot1/TPP1 complex can unfold G quadruplexes of 4 repeats, resolution of G-beads may 
need additional cellular factors. Therefore to determine if hPot1 and the hPot1/TPP1 complex 
can open up G-beads on, hPot1 or hPot1-TPP1 complexes were bound to G-rich ss telomeric 
DNAs with the preexisting G quadruplexes. Secondary structures induced by G-rich ss 
telomeric DNA (Figure 3.3A) presented more open structures upon protein binding. In the 
presence of hPot1 and the hPot1-TPP1 complex, EM revealed that protein bound DNA 
molecules present open and uniformly coated structures indicating that hPot1 (Figure 3.3B) 
and the hPot1-TPP1 complex (Figure 3.3C) form filaments on G-rich DNA. To determine if 
hPot1 and the hPot1/TPP1 complex open up the G quadruplexes, the thickness of the 
filaments from various locations were measured and compared to the thickness of G-
quadruplex. Thickness distribution of G DNA (Supplementary Figure 3.3A), and the 
filaments formed by hPot1 (Supplementary Figure 3.3B) and hPot1-TPP1 complex 
(Supplementary Figure 3.3C) fit a Gaussian distribution.   
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Figure 3.3: hPot1 and hPot1-Tpp1 open G-beads as they form filaments. Tungsten shadowcast 
images of G-rich ss DNA (A), hPot1 bound to G-rich ss DNA (B), hPot1-TPP1 bound to G-rich ss 
DNA (C). Images are shown in reverse contrast and each size bar corresponds to 50 nm. Chart (D) 
represents thickness of G-rich ss DNA, hPot1 filaments, and hPot1-TPP1 filaments. hPot1-TPP1 
filaments have less number of kinks (E) and higher number of nucleotides between each kink (F) than 
hPot1 filaments. Chart in (G) shows the kink angle difference between hPot1 and hPot1-TPP1 
filaments. * is p<0.05, ** is p<0.01 and p<0.001 is represented by *** or ****. 
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Supplementary Figure 3.3: Histograms of filament thicknesses. (A) represents the width distribution 
of G-rich single stranded telomeric DNA while (B), and (C) present the width distribution of 
filaments formed by hPot1 and the hPot1-TPP1 complex when they are bound to the G-rich ss 
telomeric DNA respectively.   
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The average thickness of G-rich telomeric DNA was found as 11 nm, while the thickness of 
the hPot1 filament was 5.5 nm and the hPot1-TPP1 filament was 8.2 nm (Table 3.2). In each 
case, the filaments formed by the proteins were significantly thinner than G-rich DNA alone 
(Figure 3.3D) suggesting that hPot1and hPot1-TPP1 complex has the ability to open up the 
preexisting G quadruplexes by forming filaments along them. 
DNA binding properties of hPot1 changes upon complex formation with TPP1 such that 
the affinity of the complex increases by 10 fold (16). Also hPot1 in complex can slide along 
G-rich DNA while hPot1 alone cannot (11). Therefore, the filaments formed by the two 
proteins can differ in their stiffness. The stiffness of the filaments can be implied from the 
kink angles and the number of kinks along a certain DNA length. Stiffer filaments tend to 
have bigger kink angles due to lower twist flexibility and lower number of kinks per unit 
DNA length. To determine the number of kinks per unit DNA length, the total number of 
kinks were counted and divided by the total length of the DNA. There is significant 
difference between the average kink number of the hPot1 filaments and the Pot1-TPP1 
filaments (Figure 3.3E). While hPot1 filament has ~25 kinks per um of DNA 
(Supplementary Figure 3.4A), hPot1-TPP1 filament has ~19 kinks per um DNA 
(Supplementary Figure 3.4B). To determine the kink angle of each filament, all the kink 
angles along a single filament were measured and their mean values were calculated 
(Supplementary Figure 3.5 A and 3.5B). The mean kink angle of all hPot1 filaments 
presented a significantly smaller angle (69°) than filaments formed by hPot1-TPP1 (98°) 
(Figure 3.3F). These data together suggest that as a result of filament formation, DNA is 
stiffer and as hPot1 forms more flexible filaments, hPot1-TPP1 forms more rigid filaments.  
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 # Particles Analyzed Average Thickness (nm) 
Standard Error 
(nm) 
G-rich telomeric 
DNA 34 10.58 0.2 
hPot1 122 5.5 0.1 
hPot1-TPP1 97 8.2 0.1 
 
Table 3.2: Thickness comparison of G-rich ss DNA, hPot1 filaments and hPot1-TPP1 complex 
filaments. The statistical analysis of the filaments widths, which were determined by Gatan software 
are presented in nm. Histograms of filament widths are shown in Supplementary Figure 3.3. 
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Supplementary Figure 3.4: Frequency distribution of number of kinks per unit DNA length. (A) and 
(B) show the filaments of Pot1 and Pot1-TPP1 complex respectively. Unit DNA length is um. 
Statistical analysis is done by Student’s t-test (Graphpad Prism 5). 
 
 
Supplementary Figure 3.5: Histogram of kink angles. Each angle was measured by ImageJ angle 
tool and Graphpad Prism5 was used for the statistical analysis. 
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hPot1 present different modes of binding and can compact ss DNA by ~ 2 fold 
We showed that both hPot1 and the hPot1-TPP1 complex relaxes G-quadruplexes by 
forming filaments on long G-rich DNA however, they could employ different DNA binding 
mechanisms to protect the chromosome ends. To determine the differences between the DNA 
binding properties of hPot1 and the hPot1/TPP1 complex at chromosome ends in more detail, 
we used a model telomere and telomeric 3-way junction templates to mimic the human 
chromosome ends and telomeric fork structures. Mass of each protein bound to the DNA 
template was determined by measuring its 2D projection and then the mean value was 
converted in to mass in kDa by using Ferritin as a size standard (Materials and Methods). 
When hPot1 or the hPot1-TPP1 complex was incubated with model telomeres at saturating 
levels (~ 95 ± 2 % total binding), DNA bound protein mass differed depending on the length 
of the overhang and the protein used (Table 3.3). When the overhang length was 50 nts, the 
mass of hPot1 was 163 ± 1 kDa and the mass of the hPot1-TPP1 complex was 132 ± 1.5 
kDa. When the overhang length was increased to 90 nts, the mass of hPot1 increased to 314 
± 1.2 kDa but the hPot1-TPP1 complex mass stayed similar (139 ± 3.8 kDa) suggesting that 
the DNA binding ability of the hPot1-TPP1 complex was independent of the DNA length. 
Mass of TPP1 is ~ 60.7 kDa (14) and hPot1 and hTPP1 is suggested to be in 1:1 ratio (30). 
Therefore, Pot1-TPP1 complex can bind to model telomere overhangs as a monomer of each 
protein. 
In solution, hPot1 exists as a monomer with a mass of 75 kDa (Supplementary Figure 
3.6), which is consistent with previous publications (~71 kDa) (31). While hPot1 binds to 50 
nts overhangs as two monomers, it binds to 90 nts overhangs as four monomers (Table 3.3). 
If only the two OB folds were responsible for the DNA binding ability of hPot1 as suggested 
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previously (25), then each monomer of hPot1 should bind to ~9-10 nts and the mass of hPot1 
bound to 50 nts and 90 nts overhangs should be 350 kDa (pentamer) and 630 kDa (nonamer). 
However, only half of the expected oligomer numbers were observed at the overhangs and in 
each case Pot1.  
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 DNA length 
# Particles 
Analyzed 
Observed 
Mass 
(kDa) 
St error 
(kDa) 
Monomer 
Mass 
(kDa) 
Oligomers 
hPot1 
50 nts 
overhang 66 163 1 71.4 2.3 
90 nts 
overhang 168 314 1.24 71.4 4.4 
124 nts 
circle 91 711 9 71.4 10 
hPot1-
TPP1 
50 nts 
overhang 37 132 1.5 61+71.4 1:1 
90 nts 
overhang 23 139 3.8 61+71.4 1:1 
 
Table 3.3: Mass analysis of hPot1and hPot1-TPP1 at model telomere overhangs. 2D area projections 
of the proteins were determined by ImageJ. The mass and the oligomeric states of each protein were 
determined by using Ferritin as a mass standard. 
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Supplementary Figure 3.6: Mass analysis of hPot1 in solution. (A) hPot1 and Streptavidin were 
prepared side-by-side for tungsten shadowcasting for direct size comparison. (B) The projected areas 
of hPot1 bound to the model telomere and free streptavidin were compared and used to estimate the 
mass of hPot1 bound to the telomere substrate. (C) the distribution of projected areas (Pixels) of 
hPot1 and streptavidin were compared. 
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monomer binds to ~20 nts. This data demonstrated that the full-length hPot1, which has 3 
OB folds, might bind to more nts compared to the truncated hPot1 with two OB folds.  
Some single strand DNA binding proteins with OB folds, such as RPA represent different 
modes of binding and thus it can bind to different number of nucleotides, either 8-10, 13-14 
or 30 nts. To test if hPot1 has differential DNA binding modes, we determined the mass of 
hPot1 on a rigid DNA template, G-circles and compared to the mass values on model 
telomere (Table 3.3, Supplementary Figure 3.7). G-circles are composed of 124 nts of pure 
telomeric repeats and thus up to 12 hPot1 monomers can bind. The mass of hPot1 on G-
circles was 711 kDa (10 hPot1 monomers), indicating that hPot1 can bind to ~12 nts on rigid 
DNA substrate. This finding is consistent with the previously suggested DNA binding motif 
for hPot1 however, it shows that nearly twice as much hPot1 molecules bind to the rigid 
DNA structures than flexible overhangs. Therefore, depending on the DNA template the full-
length hPot1 can bind to different number of nts. Another example of a single strand DNA 
binding protein with different modes of binding is E. coli single strand binding protein 
(SSB). With its different modes of DNA binding, SSB can wrap the DNA around itself and 
compact the DNA by ~3-folds. To test if hPot1 has the DNA compaction ability, we used a 
DNA template with 3-way junction that has ~570 nts long ss G-rich telomeric DNA (19). 
The length of SSB coated displaced strand was 26 ± 0.7 nm while the length of hPot1 coated 
displaced strand was 41 ± 1 nm suggesting that hPot1 compacts ss overhang structures by ~ 2 
fold (Figure 3.4A and B). This data suggests that hPot1 has different modes of DNA binding 
and when it binds to ~20 nts, it can compact the G-rich ss DNA by ~2-fold and illustrates 
why hPot1 cannot slide while the complex can. 
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Supplementary Figure 3.7: Mass analysis of hPot1 and the Pot1-TPP1 complex when bound to 
different DNA templates. (A) and (B) present the 2D area projection of hPot1 when its bound to 
model telomeres with 50 nts and 90 nts overhangs. The frequency distribution of the 2D area 
projection of hPot1 when it is bound to 124mer G-circles (C) and a representative EM image (D) are 
shown. Histograms of the Pot1-TPP1 complex at 50 nts (E) and 90 nts (F) overhangs of model 
telomere have similar means. Ferritin was used as a size standard for the mass conversion of the 2D 
projection values of each protein (G). 
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Figure 3.4: hPot1 compacts ss G-rich telomeric DNA by ~ 2 fold. hPot1 and SSB binds to the ss G-
rich strand of the 3-way junction template in (A) and (B) respectively. Images are shown in reverse 
contrast and the size bar corresponds to 1µm. Arrows indicate the DNA-protein complexes. The 
length analysis of hPot1 (C) and SSB (D) bound at the displaced strand, shows the mean value of the 
DNA-Pot1 complex as ~40 nm and the mean length of the SSB-DNA complex as ~26 nm. 
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DISCUSSION 
 
To understand the structures formed during telomere extension or transcription, we have 
determined the structure of telomeric G quadruplexes and DNA binding characteristics of 
hPot1 and its binding partner TPP1 along these higher order structures and telomeric 
overhangs. In this study we demonstrated that G quadruplexes compact into uniformly sized 
bead like structures and these beads are connected through linker DNA. In contrast to G-rich 
ss telomeric DNA, C-rich ss telomeric DNA lacked to form any defined secondary structure. 
We also showed that each bead is composed of ~490 nts and composed of both parallel and 
antiparallel G-quartets. G-beads did not show a significant change in structure upon addition 
of K+ or Na+ ions indicating their high stability. hPot1 and the hPot1-TPP1 complex can both 
open up G-beads by forming filaments along the G-rich DNA and filaments present 
differences in their rigidity and thickness. While hPot1 filaments have smaller kink angles, 
hPot1-TPP1 filaments are more rigid and have lesser number of kinks as well as bigger kink 
angles. At the 3’ overhang of model telomeres, the mass of hPot1-TPP1 complex was ~ 130 
kDa, which could be 1 hPot1 and 1 TPP1. While the mass of the complex was independent of 
the overhang length, hPot1 binds ~ 20 nts at model telomere ends and ~12 nts on G–circles. 
Moreover, hPot1 compacted the displaced strand of pRST5 by 2 fold indicating that hPot1 
and the hPot1-TPP1 complex have distinct DNA binding abilities along G-rich telomeric 
DNA and hPot1 can present different modes of binding.  
In this work we showed that G-rich telomeric DNA is composed of both parallel and 
antiparallel G quadruplexes. This data is consistent with (32). Long G-rich DNA was 
suggested to exist in a beads-on-a-string conformation (33). EM analysis confirmed that 
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model. Furthermore we showed that each G-bead is composed of ~ 490 nts and these are the 
biggest uniform G quadruplex structures that are identified so far. Yu et al also suggested a 
beads-on-a-string conformation for the G-rich DNA but the bead sizes were smaller than 
what we have identified (33). Moreover, we did not observe a change in the G-quadruplex 
structure in the presence or absence of Na+ or K+ in contrast to Yu et al (33). The major 
difference between the two studies can be the length of DNA used. They used oligos up to 
120 nts long while the DNA molecules used in our studies were kbs long suggesting that as 
the DNA length increases, the stability of the G quadruplexes can increase. The size of G-
beads and their stability can explain why complexes can stall the replication/transcription 
complexes and result in replicative stress. 
Recently, Hwang et al demonstrated that hPot1 unfolds the telomeric G quadruplex in a 
stepwise manner and in the presence of TPP1, the hPot1-TPP1 complex can slide along the 
quadruplex DNA (11). Consistently, we observed that both hPot1 and the hPot1-TPP1 
complex could unfold preexisting G quadruplexes and we further showed that both hPot1 and 
the hPot1-TPP1 complex form filaments along the long telomeric DNA as they open the G-
quadruplexes. Moreover, we demonstrated that filaments formed by hPot1 can be more 
flexible and have higher kink angles while filaments formed by the hPot1-TPP1 complex can 
be more rigid and continuous, which is consistent with the sliding ability of the hPot1-TPP1 
complex as indicated in Hwang et al (11). Moreover, the mass of the hPot1-TPP1 complex 
did not change depending on the overhang length of the model telomere. In this case, the 
sliding motion does not completely explain why telomeric end does not get saturated with the 
Pot1-TPP1 complex. One would expect to see more protein binding to the overhang as the 
length increases even if the complex slides from 3’ end towards the ds-ss junction site. 
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Alternatively, once TPP1-Pot1 complex binds to the far 3’ end of the overhang, the complex 
can pull the overhang end with it as it slides towards the ds-ss junction site. A loop- or a 
hairpin-like structure would form and as the complex moves G-quadruplexes would form end 
resolve. This mechanism would enable end protection as well as the mobility ability to the 
TPP1-Pot1 complex.  
We observed that more hPot1 monomers bound as the overhang length increased and the 
number of nucleotides that each Pot1 monomer bound was ~20 nts in each case. We have 
also showed that hPot1 compacts the G-rich telomeric DNA by ~ 2 fold. Compaction ability 
has not been identified before and the identified DNA binding motif of hPot1 was ~9-10 nt. 
However according to our findings this motif is only valid when the DNA substrate is a 
circle. When DNA is a flexible structure such as an overhang, then hPot1 can bind to ~20 nts 
and compacts DNA by ~ 2 fold. The reason why we observed the unique DNA binding 
ability of hPot1 could be that the DNA substrates in our experiments were very long, not 
immobilized and we used full-length hPot1 rather than a splice variant (11,25). 
Based on our data we suggest the model in which strand separation during transcription 
and the discontinuous synthesis of the lagging strand would cause G quadruplex formation 
(Figure 3.5). The resulting G quadruplexes can be very big and they can stall telomerase and 
replication/ transcription complexes. Telomeric ss DNA binding protein hPot1 can bind to 
the G-beads to relieve the replicative stress by opening up quadruplexes and forming 
filaments along G-rich DNA. This finding can explain, why hPot1 is required for efficient 
telomere C-rich strand replication in the absence of WRN. In the presence of TPP1, the 
hPot1-TPP1 complex would slide along the G-rich DNA (11), unfold the preexisting G 
quadruplexes and form continuous filaments. These filaments would prevent activation of 
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ATR and refolding of the G quadruplexes. Moreover, the filaments would create a bigger 
surface area for telomerase to be loaded and increase the processivity of telomerase. Once the 
replication/transcription finishes hPot1 can bind to the 3’ overhang and compact the single 
stranded DNA by ~2 fold either by wrapping or binding between each G-quadruplex motifs. 
In the presence of TPP1, the complex could bind to the far end of the overhang, pull the ss 
DNA as it slides and by this way it can prevent nucleolytic attack, activation of ATR and the 
access of telomerase to the telomeric end.  
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Figure 3.5: Model of structures formed by G-rich telomeric DNA and their regulation. Leading 
strand is synthesized continuously (I) in contrast to lagging strand synthesis. G-quadruplexes form on 
the lagging strand or when the two strands melt for transcription (II). G-quadruplexes exist as a beads 
on a string pattern (III). hPot1 opens up the G-quadruplexes and forms flexible filaments (IV). In the 
presence of TPP1, Pot1 slides and the Pot1-TPP1 complex make smoother filaments (V). At the end 
of replication or transcription, hPot1 compacts the single stranded G-rich telomeric DNA and 
TPP1/Pot1 complex holds the ss overhang end and pulls it and prevents nucleolytic attack (VI). 
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CHAPTER 4: SINGLE STRANDED TELOMERIC CIRCLES COMPLEMENTARY 
TO THE NATURAL TELOMERE OVERHANG CAN SERVE AS TEMPLATES FOR 
TELOMERASE-INDEPENDENT TELOMERE EXTENSION 
 
SUMMARY 
The Alternative Lengthening of Telomeres (ALT) pathway is a recombination-based 
telomere length maintenance mechanism observed in ~15% of human cancers. Single 
stranded and double stranded telomeric circles (t-circles) are markers for ALT in human 
cells. How they participate in this pathway is poorly understood but has been suggested to 
involve rolling circle replication (RCR) or recombinational mechanisms. To investigate how 
t-circles may facilitate telomere extension in the absence of telomerase we employed highly 
purified phage T4 replication proteins, a model telomere DNA with a 3’overhang of the G-
rich strand, and 120 nt single stranded t-circles formed from G-rich or C-rich telomeric 
repeats. We show that C-rich t-circles can anneal to the 3’overhang of the telomere and act as 
a template for the synthesis of new telomeric DNA. We observed both RCR and coupled 
synthesis of the leading and lagging strands. The newly synthesized DNA was composed of 
telomeric repeats and electron microscopic analysis showed that the replication products can 
be up to 32 kb. In contrast to C-rich t-circles, G-rich t-circles did not initiate replication. 
These results show the central role of C-rich t-circles in telomere maintenance in ALT cells 
and suggest how they can generate rapid telomere length changes. 
  
 110 
INTRODUCTION 
 
Telomeres are the nucleoprotein structures that maintain genome integrity by 
distinguishing natural chromosome ends from double stranded (ds) DNA breaks and prevent 
inappropriate DNA damage response, end-to-end fusions and nucleolytic degradation (1). 
Human telomeres consist of 5 to 15 kb tracts of TTAGGG repeats and end in a 3’ single 
stranded (ss) DNA overhang of ~150 nt on the G-rich strand (2,3).  The very end of the 
telomeric DNA can loop back and invade the upstream ds region, forming a lariat like 
structure (t-loop), (4) which is regulated by both telomere-specific proteins (shelterin) and a 
larger number of general DNA repair factors acting in concert to protect the telomere ends 
from unnecessary DNA repair activity (5).  
For telomeres to function, they must maintain their length beyond a certain critical value. 
In human somatic cells, progressive shortening of telomeres with each cell division due to 
the end replication problem eventually results in genomic instability, apoptosis, or 
senescence (6-9).  Germline cells and a majority of cancer cells upregulate the reverse 
transcriptase enzyme telomerase which restores telomeric repeats to the DNA ends and 
compensates for telomere shortening (10). However roughly 10-15% of human cancers 
maintain their telomeres beyond the critical length in the absence of telomerase activity.  
These cells, termed ALT for Alternative Lengthening of Telomeres, appear to employ 
homologous recombination pathways to maintain telomere length (11).  Characteristics of 
ALT cells are telomeres that are heterogeneous in size, show rapid length changes (12), a 
high frequency of telomere sister chromatid exchange (SCE) events without an increase in 
SCE elsewhere in the genome (13), and promyelocytic leukaemia (PML) bodies (14). In 
addition, extrachromosomal DNA consisting of telomeric repeats has been noted in ALT 
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cells (15-17). We (15) showed that ALT cells contain abundant heterogeneous ss and ds 
DNA circles and that these circles (t-circles) consist of telomeric repeats.  Thus t-circles are a 
molecular marker of ALT.  
T-circles were first discovered as extrachromosomal DNA in the mitochondria of the 
yeast Candida parapsilosis by two-dimentional agarose gels and electron microscopy (EM) 
(18). In this yeast, the mitochondrilal DNA is linear yet no telomerase activity has been 
detected in the mitochondrion suggesting that t-circles provide a primary substrate for 
telomere maintenance.  Other yeast species with linear mitochondrial DNA including C. 
salmanticensis, C. metapsilosis, and  Pichia philodendri (19) also contain mitochondrial t-
circles.  T-circles have now been detected in species as divergent as Kluyveromyces lactis 
(20,21), Caenorhabditis elegans (1), Arabidopsis thaliana (22), and Xenopus laevis (23), in 
addition to mammalian ALT cells (15), (17).  T-circles also arise in telomerase positive cells 
when certain telomerase components are overexpressed or mutated.   Increased t-circle 
formation was observed in human somatic cells containing a Ku86 deletion (24) and in A. 
thaliana with Ku70 deletion (22). Deletion of the basic terminus of human TRF2  (TRF2ΔB) 
results in the appearance of t-circles and this mutation also interferes with recruitment of 
XRCC3 (25), ORC2 (26) and WRN helicase (27) to telomeres.  The size of these circles 
ranges from 100 bases to more than 30 kb (28). Studies in K. lactis showed that t- circles 
have a role in telomere maintenance and that introduction of artificial t-circles into these 
yeast cells could lead to telomere elongation (29). This wide prevalance, presence in normal 
C. elegans cells (1) and yeast mitochondria (18), and their appearance when a number of 
telomere-related proteins are mutated suggests that t-circles are an important player in 
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telomere maintenance. Tomaska et al (30) have suggested that they may preceed telomerase 
in evolution as a means of maintaining telomere length.   
It is currently unclear how, at a molecular level, t-circles arise or are maintained.  
Possible origins include the trimming of t-loops or intrachromosomal recombination within 
telomeric arrays (30,31). In ALT cells, the reduction of XRCC3 or NBS1 (32) was found to 
reduce the level of t-circles greatly although the cells remained phenotypically ALT. The 
way in which t-circles are utilized to extend telomeres is also debated. One model suggests 
that priming occurs extrachromosomally with the t-circles generating rolling circle tails that 
produce long duplex telomeric DNA segments that can then integrate back into the telomere. 
In another model, telomere elongation and rolling-circle replication occurs together with the 
3’ overhang of the telomere annealing to a ss t-circle of the complementary sequence which 
then creates a rolling circle template. The latter mechanism is illustrated in Figure 4.1. The 
goal of this study was to test the latter model in which telomere elongation occurs via t-circle 
priming from the telomeric 3’ end. To do this we used model telomere templates and a well-
defined replication system. 
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Figure 4.1: Model of t-circle mediated telomere extension primed from the 3’ end of the telomere. 1) 
The model telomere consists of nontelomeric sequences followed by 190 TTAGGG repeats ending in 
a single stranded tail of 20 TTAGGG repeats. Asteric shows the site of radioactive labeling. 2) C-rich 
t-circle annealed to the complementary sequences in the 3’ overhang. 3) Annealed circle is used as a 
template for the new synthesis of DNA by the T4 replisome.  Priming occurs from the 3’ end of the 
model telomere. 4) RCR through the C-circle with T4 replisome. 5) Lagging strand synthesis in the 
presence of primase 
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EXPERIMENTAL PROCEDURES 
 
Plasmids and model templates:  
A model linear telomere containing a 3’ ss overhang was generated from a linearized 
plasmid DNA (pRST5) as described previously (33). A 124 nt oligo 5’-AGGG[TTAGGG]20-
3’ was synthesized and PAGE purified by Integrated DNA Technologies (lowa City, IA) and 
50 pm of the oligo was labeled with 50 pmol of γ 32P-ATP in 70 mM Tris-HCl pH 7.6, 
10 mM MgCl2, 5 mM dithiothreitol (DTT), with 20 units of T4 polynucleotide kinase (NEB 
Beverly, MA) at 37°C for 30 min. A ten fold molar excess of the oligo over the linear 
template (using 12.5 pmol of oligo) was incubated in 50 mM Tris-HCl pH 7.5, 10 mM 
MgCl2, 10 mM DTT, 1 mM ATP with 200 units of T4 DNA ligase in a 200 µl volume at 
room temperature for 20 min. The free ss oligos were removed with an ultra 0.5 Centrifugal 
filter as directed by manufacturer (Amicon Bioseparations, Raleigh, NC). 
A circular plasmid containing a ~400 nt displaced 5’ terminated ss tail (pGLGAP) was 
prepared as described previously (34). The 5- terminal phosphate was removed with 3 units 
of Antarctic phosphatase (NEB Beverly, MA) (1 pmol template) in a 20 µl volume of 
Antarctic phosphatase reaction buffer for 15 min at 37°C followed by heat inactivation for 5 
min at 65°C. The 5’ terminus was labeled with γ 32P-ATP using 20 units of T4 
polynucleotide kinase (NEB Beverly, MA) as above.   
 
Generation of telomeric circles: 
C circles: Oligonucleotides 5’-(phosphate)[CCCTAA]20-3’ were  synthesized and PAGE 
purified by Midland Certified Reagent Company (Midland, TX). Lyophilized oligos were 
resuspended in 20 µl of circularization buffer (33 mM Tris acetate pH 7.8, 66 mM KCl, 0.5 
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mM DTT  2.5 mM MnCl2, 1 M betaine), and CircLigase II (Epicentre Biotechnologies, 
Madison, WI) (100 units) ss DNA ligase was added for 16 h at 60°C followed by heat 
inactivation of the enzyme for 10 min at 80°C. Exonuclease I (NEB Beverly, MA) (20 units) 
and exonuclease III (NEB Beverly, MA) (100 units) were then added for 3 h at 37°C to 
remove any non-circularized ss DNA substrate, followed by heat inactivation at 80°C for 30 
min.  
 
G circles: A 124 nt oligo 5’-(phosphate)AGGG[TTAGGG]20-3’ was synthesized and PAGE 
purified by Integrated DNA Technologies (lowa City, IA). The lyophilized oligos were 
resuspended in 20 µl of circularization buffer and circularized exactly as above including 
post treatment with exonucleases.  
 
Replication reactions with purified T4 proteins 
To generate templates consisting of the linear model telomere annealed to a ss t-circle, or 
control oligos, the radioactively labeled model telomere DNA (0.05 pmol in a 20 µl volume) 
was incubated with a 5 fold molar excess of t-circles or linear telomere oligos in 2 mM 
Hepes pH 7.5 with gradual cooling from 65°C to 37°C over 30 min.  
The T4 replication proteins 43 polymerase, 61 primase, 51 helicase loader and 32 single 
strand binding protein were the generous gift from Dr. Nancy Nossal, and 41 helicase 
primase, 45 clamp, 44/62 clamp loader were purified by Dr. Sezgin Ozgur in this laboratory 
(to be described elsewhere). Full double strand replication reactions were carried out using 
30 nM 43 polymerase, 64 nM 61 primase, 95 nM 59 helicase loader, 242 nM 44/62 clamp 
loader, 162 nM 45 clamp, 2 µM gene 32 protein and 328 nM 41 helicase at 37°C in the 
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presence of 25 mM K-Hepes (pH 7.6), 60 mM K acetate, 6 mM Mg acetate, 2 mM ATP, 0.25 
mM CTP, 0.25 mM GTP, 0.25 mM UTP, 0.25 mM dATP, 0.25 mM dGTP, 0.25 mM dTTP, 
0.25 mM dCTP, 20 ng/µl BSA, 10 mM beta mercaptoethanol in a 50 µl volume. The 
reactions (10 µl) were quenched at 0, 1, 2, 4, 8, 20 min with 3 µl of 90 mm EDTA, 6% SDS, 
30 % glycerol, 0.25 % bromophenol blue, 0.25 % xylene blue, incubated at 55°C for 20 min 
and loaded on to 0.5% agarose gel. The dried gels were imaged using a Typhoon 9400 
phosphoimager (Amersham Biosciences, Piscataway, NJ). For ss extensions, all the 
conditions were same as the ds extensions except that gene 61 primase was excluded. 
 
Electron microscopic analysis of the replicated DNA 
Unlabeled pGLGAP and the pRST5 model telomere annealed to C-rich t-circles were 
incubated with the T4 replication proteins as described above for 4 min. The reactions were 
stopped with 50 mM EDTA, deproteinized with 30 mM SDS and 4 µg proteinase K (Roche 
Applied Science, Indianapolis, IN) at 55°C for 1 h. The DNA was then purified by 
chromatography over agarose beads (ABT Inc., Burgos, Spain). To visualize the products of 
the ds extension reactions, the sample was prepared for EM by the cytochrome C the drop 
spreading method (35).  DNA templates replicated in the absence of gene 61 primase to 
generate only long ss tails were purified as above. To visualize this DNA, E. coli SSB protein 
(USB Inc., Cleveland, OH) (50 ng) was added to 100 µl of the agarose bead eluate and 
incubated at room temperature for 20 min, followed by fixation with glutaldehyde (0.6% 
final concentration) for 5 min. The sample was then adsorbed to thin glow discharge treated 
carbon foils followed by rotary shadowcasting with tungsten at 1 x 10-6 Torr as described 
previously (36). An FEI Technai 12 instrument (Hillsboro, OR) at 40 kV was used to capture 
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the images using a Gatan Ultrascan US4000SP digital camera (Gatan, Pleasanton, CA). 
Images for publication were arranged and contrast optimized using Adobe Photoshop (Adobe 
Systems, San Jose, CA).  
 
RESULTS 
 
Generation of telomeric circles 
ALT cells contain extrachromosomal circular DNA composed of 5’-TTAGGG-3’ repeats 
(15) and can be found in ss, nicked, or ds form. In this study we constructed ss t-circles 
consisting of pure mammalian telomeric repeats as templates for telomerase independent 
replication extension reactions. A ssDNA specific ligase, CircLigase II (See Materials and 
Methods) was used to generate the t-circles from linear ss oligos (Figure 4.2A and B lane I), 
yielding 120 nt t-circles of 5’-CCCTAA-3’ and 5’-TTAGGG-3’ repeats (Figure 4.2A and B 
lanes II-III). Analysis of the circularization products on denaturing DNA gels showed that 
the circles were of a single size, and free of higher molecular weight circles (Figure 4.2A 
and B lane II). The circularization efficiency was ~40% for C-rich t- circles and ~60% for 
G-rich t- circles (Figure 4.2A and B lane II). E. coli exonucleases Exo I and Exo III digest 
linear but not circular ssDNA. Any remaining linear oligos were thus removed by treatment 
with these two enzymes (See Materials and Methods). The G-rich oligo was more resistant to 
the exonucleases likely due to the ability of the DNA to form higher order G-quadruplexes. 
Gel analysis however confirmed that ~80% of the C-rich products and ~60% of G-rich 
products remaining after exonuclease treatment were the desired t-circles (Figure 4.2A and 
B lane III). 
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Figure 4.2: Synthesis of single-stranded t-circles. Oligos 124 nt long consisting of the C-rich 
telomeric repeat (A) or the G-rich telomeric repeat (B) were treated with CircLigase II (See Materials 
and Methods) and electrophoresed on 7 M urea gels and stained with Sybergold. Lanes I show the 
unligated oligos, lanes II show the ligated oligos, and Lanes III show the ligated oligos after treatment 
with ExoI and ExoIII. 
 
C-rich t-circles mediate telomerase independent replication through a rolling circle 
mechanism 
Human chromosomes end in duplex 5’-TTAGGG-3’ repeats with a 3’ terminal ss 
overhang (3). This is modeled in the pRST5 plasmid (33) composed of non-telomeric 
plasmid sequences followed by a ~550 bp duplex tract of telomeric repeats. Linearization 
within the telomeric repeats with BsmB1 generates a 4 base overhang, used to anneal a 124 
nt long G-rich telomeric oligo to generate a 120 nt 3’ overhang (Figure 4.1).  At least 90% of 
the templates contained the overhang as assessed by the binding of E. coli SSB protein at one 
end of the DNA as seen by EM (See Materials and Methods) (data not shown).  
To examine the extension of the telomeric repeats in this model telomere by a non-
telomerase based mechanism employing t-circles, the model DNA alone, or mixed with G-
rich t-circles, C-rich t-circles, G-rich linear oligos, or C-rich linear oligos was incubated with 
the T4 replication enzymes. The model template was labeled with 32P on the 5’ phosphate of 
the 124 nt oligo used to generate the 3’ overhang to facilitate following the course of the 
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extension reaction by gel electrophoresis and autoradiography. A circular plasmid containing 
a single replication fork at a known location (34), pGLGAP, was used as a positive control 
for the replication assays. Because the T4 replication system is highly processive and 
replication proceeds rapidly, very high molecular weight DNA molecules were observed 
starting from 8 min of incubation of the forked pGLGAP template with the T4 proteins 
(Figure 4.3A lane III). As longer DNA molecules were generated, they became too large to 
pass through the gel and remained in the well (Figure 4.3A lanes III and IV). By 15 min a 
significant amount of the pGLGAP molecules had undergone replication (Figure 4.3A lane 
IV).   
When the model telomere template was annealed with the C-rich t-circles and used as a 
template for replication by the T4 proteins, a gradual increase in higher molecular weight 
products accumulating in the wells was observed after 4 min of incubation (Figure 4.3B lane 
IV). At 20 min nearly all of the model telomere DNA had replicated as evidenced by its shift 
to slower moving species (Figure 4.3B lane VI). As a control, incubation of the T4 
replication proteins with the model template annealed to the G-rich t-circles failed to 
generate higher molecular weight products (Figure 4.3D). Further, no high molecular weight 
products were detected when the model template was mixed with the linear G-rich or C-rich 
oligos, or incubated by itself with the T4 factors (Figure 4.3E, F, and G respectively). If 
extension of the telomeric sequences in the presence of the C-rich t-circles follows a rolling 
circle mechanism, then leaving out T4 primase should result in long ss tails due to the lack of 
priming on the newly synthesized ss DNA tail. When this was carried out, the labeled 
template was again shifted to higher molecular weight species that accumulated in the wells 
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of the gel (Figure 4.3C). This result supports a rolling circle mechanism of telomere 
elongation.  
Alu I and Hpa II cleave duplex DNA at 5’-AGCT-3’ and 5’-CCGG-3’ sites respectively. 
These sequences will be present in most any long DNA segment but not in telomeric DNA 
which lacks these cut sites. To further examine the nature of the replication products, 
following 15 min of extension of the telomeric template with the C-rich t-circles (a time 
when ~50% of the DNA was extended), the products were treated with Alu I and Hpa II for 
90 min (Figure 4.4B). As a control, pGLGAP, which contains Alu I and Hpa II sites was 
replicated and treated in parallel (Figure 4.4A).  As expected, complete digestion of the 
pGLGAP replication products into small sized fragments was observed (Figure 4.4A lanes 
III and IV). However with the model telomere DNA that had been extended with the C-rich 
t-circles, two different sized bands on the gel were observed (Figure 4.4B lanes III and IV). 
The lower molecular weight band corresponds to the unreplicated model telomere. Its size is 
smaller than the full-length model telomere due to Hpa II and Alu I sites within the plasmid 
segment. The high molecular weight material including DNA in the well of the gel 
corresponds to the uncleaved extended telomeric DNA formed by t-circle dependent 
replication. These results confirm that the replication products are composed of telomeric 
repeats and that the C-rich t-circles act as substrates in the extension reaction.  
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Figure 4.3: T-circle mediated telomere extension. Different templates for t-circle mediated telomere 
extension by the T4 replication proteins and a control 32P labeled forked circle were incubated with 
the purified T4 replication proteins for 0 to 20 min and then electrophoresed on 0.5% agarose gels. 
(A) pGLGAP, a plasmid circle containing a pre-formed fork as a control; (B) 32P labeled pRST5 
model telomere annealed to C-rich t-circles, (C) C-rich t-circles in the absence of gp 61 primase for 
single strand extension, G-rich t-circles (D), C-rich linear telomeric oligo (E), G-rich linear telomeric 
oligo (F), and the model telomere alone (G). Reaction time increases from lanes I to VI in each panel. 
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Figure 4.4: Restriction digestion of the replication products confirms the amplification of telomeric 
repeats. The telomeric sequences extended by t-circle dependent replication should be resistant to 
cleavage by restriction enzymes while the replicated pGLGAP plasmid would be cleaved.  (A) 
pGLGAP containing a 32P labeled pre-formed fork and replicated with the T4 proteins. (B) pRST5 
model telomere 32P labeled at the overhang, annealed to C-rich t-circles  and extended for 15 min with 
T4 replication proteins (lanes II). Both pGLGAP and the model telomere were treated with either Alu 
I (lanes III) or Hpa II (lanes IV) for 90 min following replication. Asterics correspond to the digested 
nontelomeric sequences. Repetitive sequence containing replication products remain in the wells in 
lanes III and IV (B). 
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Visualization of extension products by electron microscopy 
EM was used to visualize the products of the telomere extension reactions. Reactions 
with the model telomere annealed to C-rich t-circles (4 min) were carried out followed by 
deproteinization and purification over an agarose bead column. The DNA was then spread on 
a film of denatured cytochrome-C protein at an air-water interface (See Materials and 
Methods). This provided a direct means of visualizing very long DNA products. The EM 
analysis confirmed that the majority of the DNA molecules were extended with products 
varying in length from 4 to 32 kb (Figure 4.5A, B and D).  
The products of the 4 min extension reactions lacking T4 primase (see above) were 
deproteinized, passed through a sizing column, and then incubated with SSB protein to stain 
the ssDNA. The resulting complexes were prepared for EM by mounting onto thin carbon 
supports, air drying and rotary shadowcasting with tungsten (See Materials and Methods).  
Examination revealed very long ssDNA segments bound by SSB (Figure 4.5C), further 
supporting a rolling circle mechanism of telomere extension.  
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Figure 4.5: EM analysis of the products of t-circle mediated telomere extension. (A, B) The model 
telomere, pRST5 was annealed to C-rich t-circles and extended by replication for 4 min with the 
complete set of T4 replication factors. The purified DNA was spread on a denatured film of 
cytochrome C at an air-water interface and prepared for EM (See Materials and methods).  The 
lengths of the molecules are:  4.6, 6, 6 and 32.7 kb (A), and 3.5 kb, and 31 kb in  (B). (C) Single 
stranded DNA formed from the replication of the model telomere as in A and B but in the absence of 
pg61 primase was coated with SSB protein and mounted onto thin carbon films and rotary 
shadowcast with tungsten to reveal that very long single stranded products are produced in the 
absence of primase. All images are shown in reverse contrast. Size bars correspond to 500 nm in A, B 
and 200 nm in C. (D) Histogram representing the size distribution of synthesized DNA molecules.  
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DISCUSSION 
 
The aim of this study was to design an in vitro system that would allow us to address the 
question of whether t-circles can mediate telomere extension in the absence of telomerase.  A 
well-defined replication system, the highly purified T4 replication proteins, was employed 
along with a model telomere template.  Single stranded C-rich t-circles and G-rich t-circles 
composed of pure telomeric repeats were prepared and these t-circles or the linear oligos of 
the same sequences were incubated with the model telomere template in the presence of the 
T4 proteins. The results demonstrate that the telomeric tract in the model telomere can be 
extended to over 50 times its initial length in a reaction dependent on the replication factors 
and the C-rich t-circles. G-rich t-circles or the linear oligos could not mediate telomere 
extension. The products were resistant to four base cutters and were single stranded when T4 
primase was omited.  
We chose to use the bacteriophage T4 system for this study as the proteins are highly 
purified, available in our laboratory and are free of nucleases. The mechanism of replication 
by the T4 proteins is well characterized and provides an excellent model for the complex 
multienzyme replication systems in eukaryotic organisms (37). Moreover, the T4 replication 
complex can self-assemble in vitro and the parameters of synthesis are similar to those 
measured in vivo (38). The aim in this study was to ask if telomeric circles can initiate 
telomere extension and the T4 replication proteins have shown that this can occur. Now that 
this is known, in future studies we will examine the ability of semi-purified extracts from 
human cells to carry out similar extensions.  
The potential role of C-rich t-circles in telomere replication has been discussed 
previously.  Lindström et al (39) prepared nanocircles with telomeric repeats and annealed a 
 126 
primer to show that Φ 29 DNA polymerase would extend the primer.  Similarly, Henson et al 
(40) used C-rich t-circles with a linker sequence acting as a primer for extension with Φ 29 
DNA polymerase in their assay to detect ALT activity and showed that C-rich t-circles can 
self-prime RCR in vitro. Our study extends these reports by showing that C-rich t-circles can 
anneal to a 3’ overhang typical of that found on human telomeres and then use this overhang 
as a primer for telomere extension.  Moreover, we have shown that a well characterized 
replication system comprised of a DNA polymerase, its sliding clamp, clamp loader, primase, 
helicase, helicase loader, and a single strand binding protein will use this template in a very 
efficient manner to extend the 576 bp telomeric tract to over 50 times its starting length.  This 
extension was observed as new ds telomeric sequences or ss telomereic DNA if primase was 
omitted.  
T-circles have been suggested to result from the cleavage of t-loops (15) which resemble 
homologous recombination (HR) intermediates and thus would be prone to cleavage by 
proteins that resolve such structures.  This suggestion is supported by the finding that the size 
of t-loops and t-circles are closely correlated (15) , (20) and the observation that the 
continued presence of t-circles in ALT cells requires normal levels of two recombination 
factors,  XRCC3 and Nbs1 (32).  Telomere rapid deletion, which is a Rad 52 dependent 
shortening of overly long telomeres in S. cerevisiae, results in t-circle formation, is also 
believed to have a t-loop intermediate (41). A similar telomere trimming mechanism and t-
circle formation is observed in telomerase positive human cells when their telomeres are 
overextended by overexpression of telomerase components (42).  Deletion of Ku 70/80 in A. 
thaliana (22), induced loss of Ku86 in human somatic cells (24), overexpression of TRF2 
lacking its basic domain (25), depletion of ORC2 (26) or WRN helicase (27) all result in the 
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appearance of t-circles. These observations argue that alteration or abrogation of any of a 
number of genes needed for normal telomere maintenance or telomere-related DNA repair 
result in changes in the telomere, signaled by the appearance of t-circles.  Nonetheless the 
exact proteins involved in t-circle generation or maintenance in ALT cells remains unclear.  
The mechanism of telomere length maintenance in the absence of telomerase is not well 
understood. Two different general recombination based mechanisms have proposed: unequal 
telomere sister chromatid exchange (43) and HR dependent DNA replication in which the 
template can be t-loops, sister chromatids or t-circles (44-46).  The mechanism for which 
there is the most experimental evidence is circle mediated telomere extension, which falls 
within the latter general mechanism (15,18,25,29).  The results of our study described here 
further extend our understanding of how RCR priming can occur and show that it can be 
initiated from the end of the telomere.  Moreover, our results provide direct clues for why 
telomeres in ALT cells are able to expand so quickly.   
In our model, telomere extension occurs directly from the 3’ telomere overhang. In such 
an expansion, the 3’ ss telomere overhang anneals to a C-rich t-circle and acts as a primer for 
new DNA synthesis by using the circle as a template. Circle-mediated replication would then 
result in very long arrays of telomeric sequences being rapidly added to the telomere (Figure 
1). Double stranded t-circles can also promote circle based telomere extension however, the 
3’ overhang first needs to invade the duplex circle and then extension can be catalyzed. In 
contrast, in a model based on RCR occurring extrachromosomally, in that case, telomeric 
circles produce new telomeric DNA, which is then added to the chromosome end. Here both 
C-rich t-circles and G-rich t-circles would have similar probabilities of replication. The 
observations of Henson et al (40) provides further support for our model.  They showed that 
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there are a hundred-fold fewer G-rich t-circles than C-rich t-circles in ALT cells (~1000 C-
rich t-circles per ALT cell) and that C-rich t-circles are present in blood of ALT-positive 
osteosarcoma patients (40). Also they showed that C-rich t-circles are ~750 times more 
abundant in ALT cells than in telomerase positive cells or in non-immortalized cell strains.  
Finally, ALT activity (extension of the partially double stranded C-rich t-circles with Φ 29 
DNA polymerase) was directly correlated with the abundance of C-rich t-circles with the 
level of C-rich t-circles decreasing rapidly when the ALT activity was inhibited.  Their 
findings together with the work described here illustrates why C-rich t-circles would be 
specific to ALT cells and how they are able to extend telomeres in the absence of telomerase.  
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CHAPTER 5: CONCLUSIONS AND FINAL THOUGHTS 
 
The repetitive character of the G-rich telomeric DNA strand enables the formation of 
unique secondary structures such as t-loops and G-quadruplexes at chromosome ends (1,2). 
While both t-loops and G-quadruplexes prevent exonucleolytic attack to the telomeric 
overhang (3), they need to be resolved in S-phase for replication to occur. Failure to do so 
results in replicative stress and check point activation (4). Moreover, t-loops are suggested to 
be the origin of t-circles (3), which are the markers of ALT (5). Therefore, regulation of t-
loop and G-quadruplex structures could be important for normal cellular processes and for 
prevention of ALT. ALT is a recombination based telomere extension mechanism, found in 
~15% of cancer cases, though the exact molecular mechanism of ALT remains to be solved 
(6). Rap1, TRF2 and Pot1 are known to suppress recombination and thus might have role in 
the repression of ALT (7). The aim of this study was to understand the functional interactions 
of shelterin components hRap1, hPot1 and their associated complexes TRF2/Rap1 and 
hPot1-TPP1 with telomeric DNA. This study also addressed how shslterin components 
regulate telomere topology, and if t-circles can act as a substrate for ALT. Findings in this 
work suggest that prevention of ALT in healthy cells could be a two-step process. While the 
DNA binding ability of Rap1 induces the first level of prevention, Pot1 brings the second 
level of control through its G-quadruplex resolution function. 
In the second chapter of this study, I demonstrated that hRap1 directly interacts with 
DNA in the absence of hTRF2 and prefers to bind to the junction structures without a 
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sequence preference. Moreover, hRap1 forms a tetrameric complex with hTRF2 and the 
complex has a ~2 fold higher affinity for ds telomeric regions and ~10 fold higher affinity for 
telomeric ds-ss junction sites when compared to hTRF2 alone. Even though hRap1 cannot 
initiate t-loop formation on its own, the TRF2/Rap1 complex facilitates a higher percentage 
of t-loops than TRF2 alone indicating that hRap1 modulates t-loop dynamics by affecting 
hTRF2. This finding is important for telomere end protection and the prevention of t-circle 
formation. 
In the third chapter, I illustrated that G-rich ss telomeric DNA forms uniform higher 
order bead structures that are connected through linker DNA. Each bead is composed of 
~480 nucleotides and is a mixture of both parallel and antiparallel type G-quadruplexes. 
hPot1 and the hPot1-TPP1 complex can open up the preexisting G-quadruplexes on their 
own and form filaments along the G-rich DNA as they melt the quadruplexes. The hPot1-
TPP1 complex binds independent of the telomere overhang length, while hPot1 alone 
saturates the telomeric overhang as monomers by binding to ~20 nucleotides at a time and 
compacting the DNA length two fold. This finding indicates that hPot1 alone and the hPot1-
TPP1 complex present different DNA binding properties while modulating G-quadruplex 
structures and which would prevent recombination between G quadruplexes. 
In the fourth chapter, I demonstrated that C-rich t-circles act as a substrate for the 
telomere extension reaction while G-rich t-circles or linear G- or C-rich DNA cannot. 
Modulation of the primase in the multi component in vitro replication system with the T4 
replication complex illustrated that telomere extension with C-circles is both rolling circle 
replication and coupled replication. The length of the DNA products presented a 
heterogeneous distribution and could extend over 50 kbs in 4 minutes, meaning that the rate 
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of extension around the C-circle is ~100 rounds/minute. This finding could explain the 
heterogeneous character and rapid changes in ALT lengthened telomeres. 
The mechanisms of ALT are suggested to be recombination mediated (8) and deletion of 
hTRF2, hPot1 and hRap1 result in T-SCEs indicating that they can suppress ALT (7,9,10). 
The finding that there is no change in the total levels of hRap1 in ALT cells (11) indicates 
that ALT initiation is not dependent on Rap1’s expression levels but rather dependent on its 
localization on the DNA and/or the post-translational modifications. Therefore, 
understanding the DNA binding ability of hRap1 is a key to understand how hRap1 exerts 
these functions. The work presented here suggests three different ways how hRap1 can 
suppress ALT initiation. First, hRap1 has a high preference for ds-ss junctions, which could 
suppress HR directly (Model 1A). Second, hRap1 can stabilize telomeric ends and prevent t-
circle formation by interacting with hTRF2 and increasing hTRF2’s affinity for junctions and 
ability to form/stabilize t-loops (Model 1B). Finally, the TRF2/Rap1 complex presents 
higher affinity for ds telomeric sequences which would facilitate its binding to subtelomeric 
sites (Model 1C). Since there is no evidence suggesting one model over the other, we believe 
that all three mechanisms could be occurring simultaneously. In support of Model 1C, yRap1 
is engaged in subtelomeric silencing (12). There is also evidence suggesting that hRap1 and 
mRap1 are enriched at subtelomeric regions (12-15). Therefore we believe that hRap1 could 
induce subtelomeric silencing as yRap1 does.  
In our model we believe that hRap1 could recruit chromatin modifiers such as ATRX to 
induce silencing and to decrease TERRA expression. ATRX/DAXX localize to 
heterochromatin and PML bodies (16). Loss off or mutations in ATRX, DAXX and H3.3 
results in an increase in TERRA levels and the presence of ALT-like long telomeres in 
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pancreatic neuroendocrine cancers, pediatric glioblastomas, other tumors and 22 ALT cell 
lines (17-22). These findings suggest that ALT is epigenetically regulated and that TERRA 
transcription can have a role in ALT initiation and maintenance, which is consistent with our 
model. It would be interesting to find out whether hRap1 interacts with chromatin modifiers 
directly and whether it induces heterochromatin formation at telomeres. This might affect the 
transcriptional levels of TERRA, and thus have a direct effect on ALT formation. 
Post-translational modifications could also alter the interaction of hRap1 with telomeric 
DNA or with its binding partner hTRF2 and thus could also lead to ALT phenotypes. In fact, 
sumoylation of hRap1, hTRF2 and hTRF1 by SMC5/6 complex facilitates APB formation as 
well as targeting of telomeric DNA to PML bodies and HR (23). Moreover, inhbition of 
SMC5/6 complex blocks HR, shortening of telomeres and causes senescence in ALT cells 
(23). Therefore sumoylation is critical for removing Rap1 from telomeres and APB 
formation. This supports our model in which hRap1’s interaction with telomeric DNA is 
necessary to inhibit ALT.  
The exact mechanism of telomeric recombination in APBs is not known and the two 
suggested mechanisms are unequal TSCEs and HR-dependent DNA replication (24). 
However, neither of these models explains why TERRA levels are high in various ALT cell 
lines and cancers. Recent data suggests that ALT is epigenetically controlled and we believe 
that hRap1 could be controlling this mechanism by binding to subtelomeric sites and 
silencing TERRA transcription. A similar mechanism that initiates recombination through 
transcription occurs at immunoglobulin switch regions (S-regions) (25). S-regions are 
composed of repetitive G-rich DNA and recombination is mediated through G-quadruplexes 
(25). Recombination only occurs when S-region is transcribed (26). Transcription causes 
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loop formation and cleavage of the loops results in circular side products (27). Consistently, 
Rap1 is enriched at S-regions and deletion of mRap1 results in increase S-region 
transcription (13) suggesting the importance of hRap1’s silencing function in recombination 
repression.  
When protection by Rap1 fails, the second level of protection against ALT can arise from 
the filament formation ability of hPot1 and the hPot1-TPP1 complex (Model 2). As hPot1 
and the hPot1-TPP1 complex form filaments, they would open up the G-quadruplexes and 
prevent the interactions between G-quadruplexes. If Pot1 and hPot1-TPP1 complex are lost, 
then the G quadruplexes can initiate recombination between each other without any 
regulation and that could lead to interstrand recombination and TSCEs. Indeed, deletion of 
mPot1 results in ~10% TSCEs (28). Moreover, it has been demonstrated that the G-
quadruplex structures formed at MSH43 minisatellite mediate recombination in vitro 
potentially by forming bimolecular quadruplexes or octaplexes between interstrand G-
quadruplexes (29). This data is consistent with our model and it is possible that G-
quadruplexes formed at telomeric sequences could initiate recombination once unregulated. 
If G-quadruplex formation is transcription coupled as in the case of switch 
recombination, t-circles can arise. These circles would be single stranded G-circles and 
double stranded t-circles, in which case the circle would be RNA/DNA hybrids. Double 
stranded t-circles would have an intact C-rich telomeric DNA strand and TERRA strand. 
Separation of TERRA or exonucleolytic digestion of RNA strand would result in C-circles, 
which in turn can act as a substrate for RCR. When TSCEs occur, the recombined sister 
chromatids could be extended as suggested in HR-dependent DNA replication model. After 
extension, the strands could be resolved by cellular factors that recognize G-quadruplexes 
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such as MRN complex. The MRN complex is the first protein to be identified as a 
component for ALT-mediated telomere maintenance (30,31). The MRN complex’s ability to 
recognize G-quadruplexes and how the conserved nuclease Mre11 cleaves G-quadruplex 
DNA has been reported (32). These two findings also support our model and suggest that 
recombination could be G-quadruplex mediated. It is always a possibility that many other 
cellular factors may be involved in this process and future research is needed to illuminate 
their function.  
The model suggested here is consistent with the previously suggested mechanisms of 
ALT. Furthermore, it incorporates the recent findings about the epigenetic control and the 
findings of this study to elucidate how DNA binding properties of hRap1 and hPot1 can 
prevent ALT. The origin of t-circles was suggested to be t-loops but conclusive experimental 
proof is lacking. This model suggests that t-circles can arise in an alternative way as well. 
Finally, according to this model G-quadruplexes are important for recombination in ALT. 
Therefore G-quadruplex stabilizers could prevent recombination by stabilizing the 
interactions within the G-beads and be used in the treatment of ALT. Recent initiatives for G-
quadruplex stabilizers as ALT therapeutics is giving promising results (33,34). So far 
stabilizers were designed by using short oligonucleotides as a template however, this work 
suggested that G-beads are very big and complex motifs. Therefore further structural analysis 
of the G-beads would help in designing new therapeutics with better pharmacokinetic 
properties and higher target specificity.  
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Figure 5.1: Models of hRap1 and hPot1 mediated ALT inhibition. hRap1 could suppress ALT by 
directly binding to the junction sites (Model 1A), by facilitating t-loop formation (Model 1B) or by 
recruiting chromatin modifiers such as DAXX/ATRX to silence the telomeres and this would prevent 
TERRA expression (Model 1C). Removal of hTRF2 and hRap1 from telomeres by sumoylation 
and/or mutations or loss of DAXX/ATRX would remove the silencing effect and telomeres would be 
prone to TERRA expression (Model 2). For the recombination to occur G-quadruplexes should form 
on the untranscribed strand. hPot1 and the hPot1-TPP1 complex could prevent ALT by forming 
filaments, which would open up the G quadruplexes and also cover them and prevent the interactions 
between G qaudruplexes. Loss of Pot1 and the Pot1-TPP1 complex would lead to recombination and 
TSCEs. After the recombined telomeres are extended, MRN complex would cleave the recombined 
G-quadruplexes to release the strands. In the meantime, if the recombination occurs 
intrachromosomally, loop structures could form. Cleavage of loops by cellular factors would result in 
the formation of ds t-circles and G-circles. The t-circles could have nicks on them and exonuclease 
action would cause C-circles. C-circles would then act as a substrate for the telomere extension by 
RCR. 
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